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Abstract
One goal underlying synthetic biology is to develop standard biological parts that
can be reliably assembled into devices encoding higher-order functions. Here, I de-
veloped a framework for engineering post-translational devices, which are devices
whose inner workings are modulated by non-covalent protein interactions and cova-
lent protein modifications. To test the framework, I designed a scaffold for engineering
post-translational devices in yeast, the Phospholocator, that can be used to assem-
ble peptide parts in order to produce devices that couple upstream kinase activity
to regulated nuclear translocation. I used the Phospholocator to design, build, and
characterize a Phospholocator device, the Cdc28-Phospholocator, whose location is
regulated by the activity of cyclin-dependent kinase Cdc28. I next engineered and
tested a Fus3-Phospholocator device, whose location is regulated by the activity of the
mitogen-activated protein kinase Fus3, in order to demonstrate that the Phospholo-
cator scaffold supports the engineering of many post-translational devices. I used the
Cdc28-Phospholocator to follow Cdc28 activity levels throughout the yeast cell cycle,
thereby illustrating the utility of the Cdc28-Phospholocator as a tool for biological
inquiry. To implement more complex functions, device engineers will want to con-
nect post-translational devices to build multi-component systems. I thus developed a
model for device composition that features a universal signal carrier that is both input
into and output from post-translational devices. The universal signal could enable
engineers to easily combine devices in any desired order, and thus build many new
post-translational systems. I next developed a set of specifications and guidelines for
designing prototypical protein parts for engineering post-translational devices that
communicate via the universal signal carrier. I used the universal signal model and
the corresponding set of device specifications to design and model a proof-of-principle.
multi-device post-translational system, a post-translational latch, that functions as
designed. Taken together, my initial experiences in engineering post-translational
devices, defining universal device signals that enable device interconnectivity, and
designing, modeling, and analyzing the model of a functional multi-device system,
along with the work of many other groups, are sufficiently encouraging to motivate
continued work on post-translational devices.
Thesis Supervisor: Drew Endy
Title: Cabot Assistant Professor of Biological Engineering
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Chapter 1
Introduction
The world we live in is a world of life. From the grassy lawns on which we play frisbee,
to the beds in which we sleep, from our tap water to our bodies themselves, every
surface that we encounter in our daily lives is teeming with complex ecosystems of
living microorganisms. These organisms replicate themselves, sense and adapt to the
world around them, swim through liquids ostensibly as dense as molasses, orchestrate
a myriad of complex chemical reactions, and play nice (and not so nice) with the other
organisms around them.
Given the diverse and complex set of functions carried out by microorganisms,
within these tiny creatures lies a vast potential for the betterment of human tech-
nologies. If we can learn to reprogram microorganisms to perform useful tasks, we will
have at our disposal adaptable, self-replicating, self-preserving machines. The field of
synthetic biology has undertaken the challenge of learning how to engineer organisms
to perform functions of interest to humans. The underlying goal of synthetic biology
is to make the process of engineering biological systems easier [31]. One approach
towards this goal is to develop standard biological parts, such as portions of proteins
called protein "domains" or functional pieces of DNA called "operators," or "cod-
ing regions," among others, that can be readily and reliably reused in combination.
Current work in biotechnology provides many examples of the successful discovery,
development, and application of ad hoc engineered biological parts. For example,
researchers discovered that, in yeast, the GAL1 gene is more highly transcribed in
the presence of the sugar galactose, with regulation occurring via a region of DNA
near the GAL1 gene called the upstream activating sequence (UAS) [91]. Researchers
then quantified GAL1 "output" levels produced in response to varying galactose "in-
put" levels [40]. Many researchers now use the GAL1 UAS to conditionally control
the expression of numerous other genes [35]. However, the use of the GAL1 UAS
also highlights opportunities to improve the quality of existing genetic parts, and to
develop engineering frameworks that enable researchers to combine parts to produce
higher-order objects, or "devices." For example, adjusting the galactose dose response
curve produced by the GAL1 UAS to be more gradual involves sophisticated research
exploring the effects of altering auto-regulatory feedback within the yeast galactose
signaling system [1]. Also, proper functioning of the GAL1 UAS requires additional
cellular factors (for example, the Gal4 protein), whose activities may be uninten-
tionally modified or disrupted in the engineering of more complex cellular systems.
Finally, the GAL1 UAS is one of only a small number of available regulatory systems
for controlling gene expression in yeast. Given the GAL1 example, and many others
[85], there is an opportunity to improve upon existing biological parts by developing
frameworks that enable the engineering of many synthetic biological parts that can
be readily reused in combination.
Various engineering disciplines provide examples of building higher-order devices
from reusable components [19]. Components are typically engineered so that they
are easy to combine and, when assembled, behave as expected. For example, raw
materials such as silicon, copper, and ceramic are refined and combined to build
electrical parts such as resistors, transistors, and capacitors, that are themselves de-
signed for assembly into electronic devices such as amplifiers and inverters. Similarly,
electronic devices are designed for assembly into electronic systems such as radios,
and so on. The overall process works, in part, because at the interface between each
level of function (the materials/parts interface, the parts/devices interface, and the
devices/systems interface), the engineering principle of abstraction is used to isolate
lower-level details from higher-level functions. For example, the user of an ampli-
fier does not need to know that the device contains silicon from a particular natural
source. In addition, the engineering principle of composition is used to proscribe how
lower-level objects should be designed and manufactured so that each can be readily
assembled into higher-level objects that function as expected. For example, electronic
devices may be produced in conformance with the specifications of a "device family,"
within which all devices accept and provide signals via a common signal carrier (cur-
rent or voltage) across a specified range of levels (for example, ± 10 mA, ± 5V).
Given such engineering foundations, many parts and devices can be readily produced
and reliably reused. For example, the Digi-key parts catalog now offers over 1,000,000
reusable electronic components that are supplied by hundreds of manufacturers [25].
Inspired by these lessons, I sought to develop frameworks that would begin to support
the engineering of biological devices from underlying genetic parts.
To start, I classified current examples of biological devices into four device families
based on the mechanisms by which device function is implemented: transcriptional de-
vices, post-transcriptional devices, metabolic devices, and post-translational devices.
Transcriptional devices are devices whose inner workings are mediated by control of
gene transcription. Examples of transcriptional devices include a band detector for
pattern formation in bacterial lawns [9], a toggle switch for memory storage [36], a cell
density-apoptosis transducer [93], and many others [85]. Post-transcriptional devices
are devices whose inner workings are modulated by mRNA processing. Examples of
post-transcriptional devices include ligand-controlled regulators of mRNA translation
[44, 10] and ribozyme-mediated switches [86], among others [87, 43]. Metabolic de-
vices are devices whose inner workings are mediated by control of enzymes that chem-
ically convert non-protein substrates into desired products. Examples of metabolic
devices include an acetyl-CoA to amorphadiene converter [54] and early studies of
the modularity and composability of polyketide synthases whose catalytic modules
can potentially be physically recombined to produce different products [20]. Finally,
post-translational devices are devices whose inner workings are modulated by con-
trol of non-covalent interactions and covalent modifications of proteins. Examples of
post-translational devices include a kinase activity detector [83], an allosteric protein
signaling switch [28], and a pulse-generator, accelerator, delay circuit and ultrasensi-
tive switch built from a kinase signaling cascade [8].
The current working examples of transcriptional, post-transcriptional, metabolic,
and post-translational devices affirm the feasibility of engineering biological devices,
and provide some insight into the advantages and disadvantages of each device fam-
ily. For example, the strengths and weaknesses of post-translational devices are well
illustrated by comparison to transcriptional devices. Transcriptional devices bene-
fit from the fact that they are comprised of functional DNA parts that can some-
times be reliably combined, such as the aforementioned GAL1 promoter. However,
a limitation of transcriptional devices is that they tend to have slow response times
that are dominated by the protein synthesis and degradation processes needed to
change device state. A second drawback of transcriptional devices is that they can
only directly impact cellular functions via the regulation of transcription. By con-
trast, post-translational devices are advantageous because they make use of some
of the most ubiquitous intracellular processes: protein-protein interactions. A sec-
ond advantage is that post-translational devices operate faster than many of the
other device types. However, a drawback of post-translational devices is that com-
bining post-translational parts is not as straightforward as combining transcriptional
parts. For example, protein secondary and tertiary structure largely determine post-
translational device function, and thus protein modules can only be reliably combined
so long as the relevant structural features are not disrupted.
Given their potential utility, I decided to work on improving the process of en-
gineering post-translational devices. I initially focused on a specific class of post-
translational devices that are regulated by phosphorylation, because phosphorylation
is known to play key roles in controlling such important cellular functions as the ac-
tivation, localization, and degradation of proteins [18, 45, 24]. I decided to work in
the yeast Saccharomyces cerevisiae, because (i) yeast implements complex phospho-
mediated functions that can be leveraged to engineer interesting devices, and (ii) yeast
is a well-studied microorganism that is easy to culture and genetically manipulate.
In this dissertation, I detail my work in designing, modeling and building post-
translational devices, and developing frameworks and specifications that will po-
tentially enable other engineers to more easily build post-translational devices and
systems in the future. In Chapter 2, I develop a framework for engineering post-
translational devices, and use the framework to engineer two nuclear translocating
devices. The framework divides a post-translational device into coupled sets of re-
actions, called "input" and "output" reactions, that can potentially be individually
engineered and recombined to engineer new devices. I outline several methods for
engineering and coupling the input and output reactions, and then design and build
a protein scaffold, called the Phospholocator, that enables researchers to couple var-
ious input reactions with a common output reaction, nuclear translocation. Upon
phosphorylation of the Phospholocator by an upstream kinase, the Phospholocator
remains in the cytoplasm; unphosphorylated Phospholocator is imported into the nu-
cleus. I build and test two Phospholocator devices with different input reactions, one
that is phosphorylated by the yeast cyclin-dependent kinase Cdc28, and one that is
phosphorylated by the yeast mitogen-activated protein kinase Fus3, and show that
the two Phospholocator devices function as designed. Finally, I demonstrate that the
Cdc28-Phospholocator can potentially be used as a tool for biological discovery.
In Chapter 3, I more closely examine post-translational device signals. To im-
plement complex functions, engineers will connect post-translational devices together
to build multi-device systems. I explore the challenges inherent in connecting post-
translational devices with each other, and develop a model for device composition,
called the "universal signal" model that features a universal signal carrier that is both
input into and output from post-translational devices. The universal signal enables
engineers to easily combine devices in any desired order, and thus build many new
post-translational systems. I detail the advantages and disadvantages of the universal
signal model, and develop a set of specifications and guidelines for designing proto-
typical protein parts for engineering post-translational devices that communicate via
the universal signal carrier. Finally, I describe how engineers could build a string of
two post-translational amplifiers using the universal signal model.
Having demonstrated that engineers can build useful post-translational devices,
and defined a universal device signal that should enable post-translational devices
to be interconnected, in Chapter 4 I use the universal signal model for device com-
position and the corresponding set of device specifications I developed to design a
proof-of-principle multi-device post-translational system, a post-translational latch.
I build a model of the latch, simulate latch behavior, and demonstrate that the model
functions as designed. Finally, I develop a set of practical guidelines for building and
implementing the post-translational latch. Taken together, my initial experiences in
engineering post-translational devices, defining universal device signals that enable
device interconnectivity, and designing, modeling, and analyzing a functional multi-
device system, along with the work of many other groups, are sufficiently encouraging
to motivate continued work on post-translational device technologies in the future.
Chapter 2
Nuclear-translocating devices built
using a a post-translational
framework and scaffold
2.1 Introduction
Given the potential utility of post-translational devices in engineering organisms to
perform useful functions, I decided to work on improving the process of engineering
post-translational devices. I initially focused on a specific class of post-translational
devices that are regulated by phosphorylation, because phosphorylation is known to
play key roles in controlling such important cellular functions as the activation, lo-
calization, and degradation of proteins [18, 45, 24]. I decided to work in the yeast
Saccharomyces cerevisiae, because yeast implements complex phospho-mediated func-
tions that can be leveraged to engineer interesting devices, and yeast is a well-studied
micro-organism that is easy to culture and genetically manipulate. My goal was to de-
velop a framework for engineering phospho-mediated post-translational devices that
would enable engineers to easily combine well-characterized protein parts into de-
vices that function as designed. To demonstrate the utility of the framework, I would
use the framework to develop a scaffold for engineering post-translational devices,
and from the scaffold build several different functional post-translational devices as
proofs-of-principle. In designing the framework and building the scaffold, I would
thus outline a set of guidelines for engineering post-translational devices.
2.2 Results
2.2.1 A framework for engineering post-translational devices
To better understand and formalize the challenges of engineering post-translational
devices, I considered a theoretical post-translational amplifier, a device that receives
an input signal and produces a still greater output signal (Figure 2-1). Using the
amplifier as a prototypical post-translational device, I then developed a framework
for engineering and characterizing post-translational devices. From inspection and
previous experience with electrical devices (Introduction), I inferred that one engi-
neering challenge to be addressed by my framework is to define composable input and
output signals for the device. A second engineering challenge is to couple the input
and the output signals in a manner that implements proper device function (input
signal amplification). To enable a modular device architecture that supports the en-
gineering of many devices, I chose to divide the internal mechanisms of the amplifier
device into two sets of coupled reactions, called input reactions and output reactions.
I defined the input reactions as the set of reactions that convert the input signal to a
change in internal device state, and the output reactions as the set of reactions that
convert the change in internal device state to an output signal.
I approached the challenge of defining device input and output signals by con-
sidering the elementary chemical reactions that comprise the internal mechanisms of
the amplifier (Figure 2-2). I considered an amplifier consisting of a kinase, A, that
binds (reaction Inl) and, when active, phosphorylates a second kinase, B (reaction
In2). Upon phosphorylation, kinase B becomes activated (reaction Outl). I reasoned
that an intuitive input signal to the amplifier would be some metric for the activity
of kinase A. I noted that the net activity of kinase A can be described by two compo-
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Figure 2-1: Schematic of a black boxed post-translational amplifier, with the internal
mechanisms of the amplifier divided into two parts: the input reactions (yellow), which
convert the input signal to a change in internal device state, and the output reactions
(blue), which convert the change in internal device state to an output signal.
nents: (i) the concentration of active kinase A, and (ii) the catalytic activity of active
kinase A (katA). Similarly, the output signal of the amplifier can be described by
the concentration of activated kinase B, and the catalytic activity of kinase B (kctBs).
Electrical systems also employ two signal components, current and voltage. The two
components of kinase activity could be multiplied together to give an input signal of
the Vmax of the kinase. However, it is advantageous to define device signals in terms
of concentration and catalytic activity separately so that engineers can model device
dynamics, just as electrical engineers define current and voltage separately instead of
multiplying them together to give a signal of power. Thus, I chose to define the input
and output signals of post-translational devices to be two-component signals.
I approached the challenge of coupling the input and the output signals by consid-
ering the interface between input and output reactions. In the case of the amplifier,
the input reactions consist of kinase A binding to and phosphorylating the inactive
form of kinase B (Figure 2-2). The input reactions receive the device input signal,
the concentration of active kinase A with activity kctA, and convert this signal into
a concentration of phosphorylated kinase B. My initial device engineering framework
considers the total concentration of kinase B (the sum of the concentrations of active
kinase B and inactive kinase B) to be fixed within the device. The device output re-
actions consist of the phosphate group on kinase B causing an internal state change in
kinase B, such as a conformational change, that results in an increase in the catalytic
activity of kinase B. The output reactions thus convert the internal device state, the
L
Figure 2-2: Example inner mechanisms for a post-translational amplifier, with the input
signal defined as the activity of kinase A (green protein). The input signal is comprised of
both the concentration and catalytic activity of active kinase A. The device output signal,
similarly defined, is comprised of both the concentration and catalytic activity of active
kinase B (inactive kinase B is shown in light orange, active kinase B is shown in medium
orange). The input reactions consist of Inl (kinase A and kinase B binding and dissociation)
and In2 (phosphorylation of kinase B by kinase A). Phosphate groups are shown as stars.
The output reaction consists of Out1 (phosphate-mediated conversion of kinase B from an
inactive to active form).
concentration of phosphorylated kinase B, to an output signal defined as the concen-
tration of activated kinase B with catalytic activity ktB. In order to systematically
produce post-translational devices in accordance with my framework, one must learn
how to: (i) engineer input reactions, (ii) engineer output reactions, and (iii) couple
the input and output reactions.
Approaches to engineering post-translational device input reactions
I defined three potential approaches for engineering the input reactions of post-trans-
lational devices. Each approach involves a different mechanism for bringing the cat-
alytic domain of the input kinase into close proximity of the phosphorylation peptide
of the substrate. First, a kinase can directly bind and phosphorylate a single peptide
within the substrate. I call this mechanism of interaction the single peptide mecha-
nism. Protein kinases A and B (PKA and PKB) employ the single peptide mechanism
of substrate interaction [49, 60, 50]. Using the single peptide mechanism, Zhang et al.
fused a known PKA substrate peptide within the interior of a construct containing
two fluorescent proteins, and used changes in fluorescence resonance energy transfer
(FRET) to indirectly show that PKA phosphorylated the construct in vitro and in
vivo [95]. Second, a kinase can bind to its substrate via a binding peptide and then,
once properly associated, phosphorylate a separate phosphorylation peptide. I call
this mechanism of interaction the double peptide mechanism. Mitogen-activated pro-
tein kinases (MAP kinases) [74] and cyclin-dependent kinases (CDKs) [79, 2] both
employ the double peptide mechanism of substrate interaction. Using the double
peptide mechanism, Smith et al. demonstrated that by fusing the docking peptide
of mammalian MAP kinase p38 from MAP kinase-activated protein kinase 2 (MK2)
to Rsk2, a kinase with which p38 does not normally interact, p38 was able to bind
and activate Rsk2 [78]. As a second example, Takeda et al. demonstrated that pep-
tides consisting of the CDK phosphorylation peptide and cyclin binding peptide of
Cdc6, separated by variable length linkers, were phosphorylated by Cyclin A-Cdk2
and Cyclin E-Cdk2 [79]. Finally, a kinase can indirectly associate with its substrate
via an additional scaffold protein. The scaffold protein binds both the kinase and its
substrate, and in so doing positions the kinase such that it can phosphorylate the
substrate. I call this mechanism of interaction the scaffold mechanism. A few natural
signaling pathways have been shown to employ scaffold proteins, such as the yeast
pheromone response pathway, which contains scaffolded binding between the MAP
kinase kinase kinase, Stell, the MAP kinase kinase Ste7, the MAP kinase Fus3, and
the scaffold protein Ste5 [22, 53, 65]. Using the scaffolded mechanism, Park et al.
demonstrated that by fusing the yeast MAP kinase kinase Pbs2 to the Ste5 scaffold,
Pbs2 was activated in response to pheromone [61]. As a second example, Bashor et
al. engineered yeast phosphatase Msg5 to bind Ste5 via exogenous binding domains,
and demonstrated that Msg5 negatively modulated pheromone pathway output [8].
Approaches to engineering post-translational device output reactions
I next defined two approaches for engineering the output reactions of a post-trans-
lational device. Each approach involves a different mechanism in which a phosphate
group changes the function of the substrate to which it is covalently bound. First,
protein function can be regulated by allostery, in which the phosphate group added
by the input reactions causes a shift in protein structure that then impacts pro-
tein function. I call this mechanism of regulation allosteric regulation. MAP kinases
are activated by allostery; upon phosphorylation of the MAP kinase phosphoryla-
tion loop, MAP kinases such as Erk2, the mammalian homolog of Fus3, undergo a
structural shift that opens up the catalytic site to substrates [18]. Using allosteric
regulation, Dueber et al. have produced protein constructs, such as ligand-gated
signaling switches, which consist of the catalytic domain of an enzyme flanked by
complementary binding partners on the N and C termini. When the binding partners
bind each other, the catalytic domain is pinched shut and inactivated [28]. Second,
protein function can be regulated by motif overlapping, in which the sequence encod-
ing the phosphorylation peptide is interlaced with the sequence encoding a binding
peptide. I call this mechanism of regulation steric regulation. Phosphorylation of the
phosphorylation peptide can regulate the in trans interaction of the binding peptide
with its cognate binding domain in either of two ways. First, the negative charge of
the phosphate group on the phosphorylation peptide can either enhance or disrupt
the binding interface between the binding peptide and binding domain, altering the
affinity with which the binding domain binds the peptide. I call this mechanism of
regulation of binding direct steric regulation Alternatively, the phosphorylated pep-
tide can bind a second binding domain that competes with the first binding domain.
I call this mechanism of regulation of binding indirect steric regulation. Using indi-
rect steric regulation, Sallee et al. engineered switches consisting of two overlapping
sequences of binding peptides for various protein domains such as the PDZ, Cdc42,
SH3, and 14-3-3 domains, and demonstrated that when one binding domain bound a
given switch, the other binding domain could not also bind the switch [72].
Approaches to coupling input and output reactions
Finally, to produce a functioning device, one must be able to reliably couple input re-
actions to output reactions such that the former will appropriately regulate the latter.
Standard methods for coupling input and output reactions would allow researchers
to combine libraries of input and output reactions to produce many devices. For
phospho-dependent post-translational devices, the specific challenge in coupling input
and output reactions is to engineer a phosphorylation peptide that can interface with
both the input and output reactions. Researchers have realized this goal by engineer-
ing phosphorylation-regulated FRET reporters. For example, Ting et al. developed
reporters of in vivo kinase activity of epidermal growth factor receptor (EGFR) that
couple input reactions based on the single peptide mechanism with output reactions
based on direct steric regulation. The kinase reporters consist of an EGFR substrate
peptide, the phosphotyrosine binding domain Src homology domain 2 (SH2), and two
fluorescent proteins on the N- and C-termini of the construct. Phosphorylation of the
EGFR substrate peptide by EGFR causes binding in cis between the SH2 domain
and the EGFR substrate peptide, resulting in a conformational change, and hence a
shift in FRET, between the two fluorophores [83]. Other researchers have also ex-
plored the modularity of input and output reactions in FRET-based kinase reporters
by engineering reporters for histone kinase Msk-1 [51] and protein kinase A activity
[95] by inserting binding domains and substrate peptides specific to Msk-1 and pro-
tein kinase A between two fluorescent domains. These results suggest that new input
reactions to the FRET reporters can be interfaced with a common output reaction
(phospho-mediated binding and a resulting change in FRET). The drawback of the
FRET-based reporters is that the output signal, FRET, cannot be readily accepted as
input to other downstream post-translational devices. Thus, one of my main goals re-
mains to better couple the input and output reactions of post-translational devices to
produce devices whose input and output signals can be interfaced with other devices.
2.2.2 The Phospholocator: a scaffold for engineering nuclear
translocating devices
To better understand and address the challenges of engineering and coupling input
and output reactions, I designed a new family of post-translational devices in Sac-
charomyces cerevisiae, and built and tested two instances of the device family. I
first developed a device scaffold, called the Phospholocator, that provided a start-
ing structure onto which I fused various peptide parts, such as docking peptides and
phosphorylation peptides, in order to engineer devices with different sets of input
reactions and a common output reaction (Figure 2-3).
Figure 2-3: The inner mechanism of a post-translational nuclear translocating device.
The Phospholocator scaffold couples input reactions of kinase phosphorylation to output
reactions of regulated nuclear translocation (nuclear Phospholocator is shown in light pink,
while cytoplasmic Phospholocator is shown in medium pink). The input signal to the Phos-
pholocator is the concentration and catalytic activity of active kinase A, while the output
signal of the Phospholocator is the concentration of remaining cytoplasmic Phospholoca-
tor. Inl and In2 are similar to Inl and In2 from B, while Outl is the phosphate-regulated
translocation of the Phospholocator from the nucleus to the cytoplasm.
The input reactions consist of the input kinase binding and phosphorylating the
Phospholocator, while the output reactions consist of the phospho-regulated translo-
cation of the Phospholocator between the cytoplasm and the nucleus. To support
the engineering of input reactions, I made use of the double peptide mechanism for
mediating Phospholocator phosphorylation. I chose to use the double peptide mech-
anism because it allowed us to separate the engineering of the binding peptide from
the engineering of the phosphorylation peptide, thereby providing greater modularity
in design. I designed the Phospholocator such that any upstream kinase would bind
to its partner Phospholocator via a cognate N-terminal docking peptide, and then
phosphorylate separate phosphorylation peptides, each also specific to the upstream
kinase (Figure 2-4).
To engineer the regulated translocation output reaction, I included the 50-residue
Swi5 nuclear localization signal (NLS) as a part of the Phospholocator. Moll et al.
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Figure 2-4: A generic Phospholocator device. The docking peptide mediates binding
between the Phospholocator and an active kinase. The kinase phosphorylates the Phos-
pholocator at serine residues S15 and S33 within two kinase phosphorylation peptides.
The phosphorylation peptides are embedded within an NLS, and the negative charge from
the two phosphate groups likely prevents the nuclear import machinery from binding the
NLS; hence, upon phosphorylation, Phospholocator remains in the cytoplasm. The YFP
(Venus) segment of the construct allows visualization of Phospholocator location, while the
,-galactosidase segment slows passive nuclear pore diffusion.
showed that Cdc28 phosphorylates two serine residues embedded within the Swi5 NLS
[57]. The negative charge from the two phosphate groups likely prevents the nuclear
import machinery from binding the NLS, and hence phosphorylated Swi5 remains in
the cytoplasm. By fusing the Swi5 NLS to the Phospholocator, and replacing the
Cdc28 phosphorylation peptides with phosphorylation peptides recognized by differ-
ent kinases, I hypothesized that the cellular location of the Phospholocator could be
similarly regulated in response to the activity of different input kinases. In addition to
the docking peptide, phosphorylation peptides, and Swi5 NLS, the Phospholocator in-
cludes a Venus yellow fluorescent protein (YFP) for detection [58] and f-galactosidase,
whose additional mass retards spontaneous diffusion through the nuclear pore [3].
2.2.3 A Cdc28-regulated Phospholocator device
The first device I built using the Phospholocator scaffold was the Cdc28-Phospholo-
cator. Cdc28 is known to bind and phosphorylate the wild-type Swi5 NLS on two
peptides (KRSP and SSSP) [57]. However, the Cdc28 docking peptide within the
Swi5 NLS has not been defined. Thus, I first sought to confirm that this same Swi5
NLS, in the context of the Cdc28-Phospholocator, would be phosphorylated by Cdc28
and, if so, that the cellular location of the Cdc28-Phospholocator would be modulated
in response to phosphorylation.
I cloned the Cdc28-Phospholocator into a modified version of the yeast integrat-
ing plasmid pRS403 that contains the GAL1 transcriptional promoter and CYC1
transcriptional terminator, allowing for control of Cdc28-Phospholocator expression
using galactose [35]. I integrated the vector expressing the Cdc28-Phospholocator
into strain SST1040 expressing an analog-sensitive Cdc28 mutant (cdc28asl) in order
to allow for control of Cdc28 activity using the chemical inhibitor 1-NM-PP1 [13].
SST1040 also expresses temperature sensitive Cdc15-2, allowing for cells to be ar-
rested in telophase at non-permissive temperatures (370C) [76]. To test the behavior
of the Cdc28-Phospholocator in vivo, I arrested cells in telophase at 37 oC for three
hours, and then induced expression of the Cdc28-Phospholocator by switching car-
bon sources from raffinose to galactose in the presence of varying levels of 1-NM-PP1.
I recorded cell fluorescence micrographs 4.5 hours following Cdc28-Phospholocator
induction (Figure 2-5).
Cells exposed to both high and low levels of 1-NM-PP1 exhibit similar Cdc28-Phos-
pholocator expression levels, determined by quantifying the mean total absolute fluo-
rescence within cells using custom MATLAB image analysis scripts (not shown) and
the total band intensities of western blots of cells expressing the abridged Cdc28-
Phospholocator (Figure 2-11, see below). For example, the cells shown in Figure 2-5
have background-substracted mean total absolute fluorescence levels of 241039 (0
pM 1-NM-PP1) and 248636 (1 pM 1-NM-PP1), which differ by 3%. Using addi-
tional custom MATLAB image analysis scripts (Methods), I measured the ratio of
the average cytoplasmic fluorescence to the average nuclear fluorescence (the cyto-
plasmic:nuclear fluorescence ratio) of each cell. The cytoplasmic:nuclear fluorescence
ratio represents how effectively the Phospholocator is retained in the cytoplasm, pre-
sumably due to phosphorylation; high cytoplasmic:nuclear fluorescence ratios indi-
cate high cytoplasmic retention and phosphorylation of the Phospholocator, while
low cytoplasmic:nuclear fluorescence ratios indicate low cytoplasmic retention and no
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Figure 2-5: The location of the Cdc28-Phospholocator is regulated by inhibition of Cdc28
activity. Cells were arrested in telophase by shifting to 37 C, and then Cdc28-Phospho-
locator expression was induced by growing cells in galactose media for 4.5 hours. Cells
were exposed to 0 IM (high Cdc28 activity) or 10 LM (low Cdc28 activity) 1-NM-PP1.
Representative images depict cell boundaries (bright field), cell nucleii (RFP filter), and the
Cdc28-Phospholocator (YFP filter). All YFP images were taken at exposure times of 0.4
seconds, and normalized together, while BF and RFP images were normalized individually.
phosphorylation of the Phospholocator.
Histograms of the cytoplasmic:nuclear fluorescence ratios of all cells incubated in 0
pM 1-NM-PP1 (high Cdc28 activity levels) or 10 IM 1-NM-PP1 (low Cdc28 activity
levels) across all trials shows that the Cdc28-Phospholocator appears to be highly
responsive to 1-NM-PP1 (Figure 2-6a; Figure 2-7). I found that the geometric mean
of the cytoplasmic:nuclear fluorescence ratios across all cells and trials decreased with
increasing levels of 1-NM-PP1 (Figure 2-6b). These results are consistent with my
design goal that the Cdc28-Phospholocator be phosphorylated by Cdc28 and as a
result retained in the cytoplasm.
The four trials, taken individually, each display a similar relationship between 1-NM-
PP1 concentration and average cytoplasmic:nuclear fluorescence ratio (Figure 2-8).
I verified that the observed 1-NM-PP1 dose response was dependent on the analog-
sensitive Cdc28asl mutant, and not due to 1-NM-PP1 itself (Figure 2-9). I addition-
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Figure 2-6: Analysis of Cdc28-Phospholocator micrographs. (A) Distribution of the cyto-
plasmic:nuclear fluorescence ratios of cells incubated in 0 pM and 10 pM 1-NM-PP1. The
dotted lines indicate population medians (0.51 and 0.68, respectively). (B) Telophase ar-
rested cells (as in A) exposed to a range of 1-NM-PP1 concentrations. The geometric mean
of the cytoplasmic:nuclear fluorescence ratio across all cells from four trials was determined
using custom MATLAB scripts; the error bars show 95% confidence intervals in the estimate
of the mean.
ally verified that the cytoplasmic:nuclear fluorescence ratios remained constant from 4
hours post-induction to 5.5 hours post-induction (Figure 2-10), and thus the Cdc28-
Phospholocator measurements appear to represent Cdc28-Phospholocator behavior
at steady-state.
I used gel shift assays to verify that Cdc28 phosphorylates the Cdc28-Phospho-
locator. Previous research has shown that phosphorylated peptides with proline as
the residue directly C-terminal to the phosphorylated residue, such as the phospho-
rylation peptides of the Cdc28-Phospholocator, sometimes migrate more slowly on
SDS-PAGE gels [43,44]. The retarded migration is most likely due to a disruption of
the SDS micelle surrounding the peptide by the negatively charged phosphate group
[Dr. Mike Yaffe, personal communication]. I thus expected the Cdc28-Phospholoca-
tor to migrate more slowly with decreasing levels of 1-NM-PP1. Given the large size
of the Cdc28-Phospholocator (155 kDa), I was unable to find or realistically construct
a gel apparatus large enough to resolve small differences in the rates of Cdc28-Phos-
pholocator migration. I constructed a smaller version of the Cdc28-Phospholocator,
called the abridged Cdc28-Phospholocator, that is identical to the full-length Cdc28-
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Figure 2-7: Variation in Cdc28-Phospholocator histograms across individual trials. The
distribution of the cellular cytoplasmic:nuclear fluorescence ratio of cells for each of the four
trials from Figure 2-6 in the presence of high (10 pM), medium (2.5 pM) and low (0 pM)
levels of 1-NM-PP1. Dotted lines indicate population medians.
Phospholocator except that it lacks 0-galactosidase and thus has a total mass of 33
kDa. I arrested cells expressing the abridged Cdc28-Phospholocator in telophase as
described above, extracted protein from the cells, and performed a western blot on the
extracts (Figure 2-11a). I found that the abridged Cdc28-Phospholocator separated
into three distinct bands, presumably representing doubly phosphorylated, singly
phosphorylated, and unphosphorylated abridged Cdc28-Phospholocator at residues
S15 and S33 (in order from the slowest- to the fastest-migrating bands).
I verified the phosphorylation state of the bands by constructing S15A and S15A/S33A
alanine mutants of the abridged Cdc28-Phospholocator and repeating gel-shift as-
says, as described above, on cells expressing each mutant (Figure 2-12). As expected,
the S15A/S33A double mutant migrated as a single band, presumably consisting of
unphosphorylated construct, while the S15A single mutant migrated as two bands,
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Figure 2-8: Variation in Cdc28-Phospholocator ratios across individual trials. The geo-
metric mean of the cytoplasmic:nuclear fluorescence ratios of cells from each of the four
trials in Figure 2-6, calculated using custom MATLAB scripts. The error bars show 95%
confidence intervals in the estimate of the mean.
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Figure 2-9: Inhibitor 1-NM-PP1 has no effect on wild-type Cdc28. SST1050 cells express-
ing wild-type Cdc28 were arrested in telophase as in Figure 2-6c and exposed to differing
concentrations of 1-NM-PP1 (blue line). The geometric mean of the cytoplasmic:nuclear
fluorescence ratios of cells from one trial was calculated using custom MATLAB scripts;
error bars show 95% confidence intervals in the estimate of the mean. For comparison, the
dose-response curve of SST1040 cells expressing the cdc28asl mutant from Figure 2-6c is
shown in black.
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Figure 2-10: Cdc28-Phospholocator measurements were taken at steady-state. SST1040
cells were arrested in telophase and the Cdc28-Phospholocator induced as in Figure 2-6.
The geometric mean of the cytoplasmic:nuclear fluorescence ratio across all cells from two
to three trials at several time points post-induction was calculated using custom MATLAB
scripts; the error bars show 95% confidence intervals in the estimate of the mean. The
legend shows concentrations of 1-NM-PP1. Measurements for Figures 2-5, 2-6, 2-11,
2-12, 2-13, 2-22, 2-7, 2-8, 2-9, 2-15, 2-14, 2-23, and 2-24 were taken 270 minutes
post-induction (dotted line).
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Figure 2-11: Analysis of Cdc28-Phospholocator gel-shift assays. (A) Western blots using
cells from Figure 2-6c. (B) phosphorylated:unphosphorylated band ratios as determined by
dividing the sum of the total intensities of the P2 and P1 bands by the total intensity of
the PO band.
presumably consisting of singly phosphorylated and unphosphorylated construct. I
quantified the abridged Cdc28-Phospholocator dose response bands by measuring the
ratio of the sum of the total intensities of the two slowest migrating bands to the
total intensity of the fastest migrating band, or the phosphorylated:unphosphoryla-
ted band ratio, and found that this ratio decreased with increasing concentrations
of 1-NM-PP1 (Figure 2-11b), which correlates well with the Cdc28-Phospholocator
microscopy data.
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Figure 2-12: Cdc28-Phospholocator mutants migrate differently in gel shift assay. Western
blots using lysates from SST1040 cells arrested in telophase as in Figure 2-5 and expressing
either the abridged Cdc28-Phospholocator, S15A-Cdc28-Phospholocator, or S15A/S33A-
Cdc28-Phospholocator.
I queried the importance of each of the two Cdc28-Phospholocator phosphory-
lation sites in regulating Phospholocator activity in vivo. I built S15A, S33A, and
S15A/S33A mutants of the full-length Cdc28-Phospholocator, and performed local-
ization assays, as described above, on cells expressing the mutants. I analyzed cell
micrographs from at least three trials, and measured the geometric mean of the cy-
toplasmic:nuclear fluorescence ratios across all cells and all trials (Figure 2-13).
The single mutant S15A-Cdc28-Phospholocator and S33A-Cdc28-Phospholocator dis-
played lower mean cytoplasmic:nuclear fluorescence ratios in the absence of Cdc28
inhibitor than did the wild-type Cdc28-Phospholocator, and higher mean cytoplas-
mic:nuclear fluorescence ratios than did the double mutant S15A/S33A-Cdc28-Phos-
pholocator. The S15A/S33A-Cdc28-Phospholocator exhibited similar mean cytoplas-
mic:nuclear fluorescence ratios at both high and low concentrations of Cdc28 inhibitor.
Each trial, taken individually, displays a similar relationship between Cdc28-Phos-
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Figure 2-13: Both S15 and S33 are important for regulation of Cdc28-Phospholocator
translocation. Telophase arrested cells (as in Figure 2-12) expressing mutant Cdc28-Phos-
pholocator constructs, exposed to a range of 1-NM-PP1 concentrations. The geometric
mean of the cytoplasmic:nuclear fluorescence ratio across all cells from four trials was de-
termined using custom MATLAB scripts; the error bars show 95% confidence intervals in
the estimate of the mean.
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Cdc28-Phospholocator mutant
Figure 2-14: Quantitation of mutant Cdc28-Phospholocator gel-shift assays. phosphoryla-
ted:unphosphorylated band ratios as determined by dividing the sum of the total intensities
of the P2 and P1 bands by the total intensity of the PO band.
pholocator mutant and mean cytoplasmic:nuclear fluorescence ratio (Figure 2-15).
Gel-shift assays on abridged Cdc28-Phospholocator mutants yielded results similar to
those of the micrograph data (Figure 2-12 and 2-14).
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Figure 2-15: Variation in mutant Cdc28-Phospholocator ratios across individual trials.
SST1040 cells were arrested in telophase and the S15A-Cdc28-Phospholocator, S33A-Cdc28-
Phospholocator, or S15A/S33A-Cdc28-Phospholocator was expressed as in Figure 3. The
geometric mean of the cytoplasmic:nuclear fluorescence ratios of cells from each of three to
five trials was measured using custom MATLAB scripts; error bars show 95% confidence
intervals in the estimate of the mean.
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2.2.4 A Fus3-regulated Phospholocator device
I next showed that I could engineer a Phospholocator device that accepts a different
set of input reactions, while maintaining the same set of output reactions. Specif-
ically, I developed a Phospholocator device that is recognized and phosphorylated
by the yeast MAP kinase Fus3. CDKs and MAP kinases both utilize the double
peptide mechanism to recognize and phosphorylate their substrates, but are struc-
turally different; active CDKs are part of a CDK-cyclin complex [15], while active
MAP kinases function without being part of a complex [28]. I chose Fus3 because it
has well-defined docking [7] and phosphorylation sites [Drs. Mike Yaffe and Wendell
Lim, personal communication], and because one can modulate Fus3 activity levels
using varying concentrations of mating pheromone [92]. I fused the Fus3 docking site
from Ste7 [7] to the N-terminus of the Phospholocator, and replaced the two Cdc28
phosphorylation peptides of the Phospholocator (KRSP and SSSP) with Fus3 phos-
phorylation peptides (PQSP and PQSP) [Drs. Mike Yaffe and Wendell Lim, personal
communication].
Cell boundary Nucleus Fus3-Phospholocator
(BF) (RFP) (YFP)
Active Fus3
(1 uM pheromone)
Inactive Fus3
(0 uM pheromone)
Figure 2-16: The location of the Fus3-Phospholocator is regulated by inhibition of Fus3
activity. SST1040 cells expressing the Fus3-Phospholocator were arrested with 10 pJM 1-
NM-PP1 for 2.5 hours at 0 pM (low Fus3 activity) or 1 MM pheromone (high Fus3 activity).
Representative images depict cell boundaries (bright field), cell nucleii (RFP filter), and the
Fus3-Phospholocator (YFP filter). All YFP images were taken at exposure times of 0.4
seconds, and normalized together, while BF and RFP images were normalized individually.
I tested the Fus3-dependent behavior of the Fus3-Phospholocator across a range of
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Fus3 activity levels by exposing cells to varying concentrations of mating pheromone,
while simultaneously inducing Fus3-Phospholocator expression from the GAL1 pro-
moter. I inhibited Cdc28 by adding 10 pM 1-NM-PP1 to all samples, resulting in
an asynchronous arrest of the cell population; Cdc28 itself inhibits pheromone arrest
[64], and thus by inhibiting Cdc28, I ensured uniform Fus3 activation in response to
pheromone regardless of cell cycle stage [23]. I recorded cell fluorescence micrographs
2.5 hours following Fus3-Phospholocator induction (Figure 2-16), and measured cy-
toplasmic and nuclear fluorescence levels as described above. Cells exposed to both
high and low levels of pheromone exhibit similar Fus3-Phospholocator expression lev-
els, determined by quantifying the mean total fluorescence within cells using custom
MATLAB image analysis scripts (not shown).
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Figure 2-17: Analysis of Fus3-Phospholocator micrographs. (A) Distribution of the cyto-plasmic:nuclear fluorescence ratios of cells incubated in 0 pM and 1 pM pheromone. Thedotted lines indicate population medians (0.27 and 0.49, respectively). (B) Arrested cells(as in A) exposed to a range of pheromone concentrations. The geometric mean of thecytoplasmic:nuclear fluorescence ratio across all cells from four trials was determined usingcustom MATLAB scripts; the error bars show 95% confidence intervals in the estimate ofthe mean.
The Fus3-Phospholocator appeared to be more nuclear than the Cdc28-Phospholo-
cator (Figure 2-5). Nevertheless, a histogram of the cytoplasmic:nuclear fluorescence
ratios of all cells incubated in 0 ipM pheromone (low Fus3 activity) or 1 pM pheromone
(high Fus3 activity) shows that the Fus3-Phospholocator appears to be highly respon-
sive to pheromone (Figure 2-17a; Figure 2-18). I found that the geometric mean of
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the cytoplasmic:nuclear fluorescence ratios across all cells and trials increased with
increasing levels of pheromone, and thus increasing activity levels of Fus3, which is
consistent with my design goal that the Fus3-Phospholocator be phosphorylated by
Fus3 and as a result be retained in the cytoplasm (Figure 2-17b).
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Figure 2-18: Variation in Fus3-Phospholocator histograms across individual trials. The
distribution of the cellular cytoplasmic:nuclear fluorescence ratio of cells for each of the four
trials from Figure 2-17 in the presence of low (0 nM), medium (0.1 nM) and high (1 pM)
concentrations of pheromone. Dotted lines indicate population medians.
The four trials, taken individually, each display a similar relationship between pheromone
concentration and mean cytoplasmic:nuclear fluorescence ratio (Figure 2-19). I ad-
ditionally verified that the cytoplasmic:nuclear fluorescence ratios remained constant
from 140 minutes post-induction to 230 minutes post-induction (Figure 2-20), and
thus the Fus3-Phospholocator measurements appear to represent Fus3-Phospholoca-
tor behavior at steady-state.
I used gel shift assays to verify that Fus3 phosphorylates the Fus3-Phospholoca-
tor. I constructed a smaller version of the Fus3-Phospholocator, called the abridged
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Figure 2-19: Variation in Fus3-Phospholocator ratios across individual trials. The geo-
metric mean of the cytoplasmic:nuclear fluorescence ratios of cells from each of the four
trials in Figure 2-17c, calculated using custom MATLAB scripts. The error bars show 95%
confidence intervals in the estimate of the mean.
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Figure 2-20: Fus3-Phospholocator measurements were taken at steady-state. SST1040
cells expressing the Fus3-Phospholocator were arrested with 10 AM 1-NM-PP1 and 1 AM
pheromone (high Fus3 activity) as in Figure 2-17. The geometric mean of the cytoplas-
mic:nuclear fluorescence ratio across all cells from two to three trials at several time points
post-induction was calculated using custom MATLAB scripts; the error bars show 95%
confidence intervals in the estimate of the mean. The legend shows concentrations of 1-
NM-PP1. Measurements for Figures 2-16, 2-6, 2-21, 2-22, 2-18, 2-19, 2-23, and 2-24
were taken 270 minutes post-induction (dotted line).
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Fus3-Phospholocator, that is identical to the Fus3-Phospholocator except that it lacks
0-galactosidase and thus has a total mass of 36 kDa. I arrested cells expressing the
abridged Fus3-Phospholocator using varying levels of pheromone, and performed a
western blot, as described above (Figure 2-21a and b). The phosphorylated:unphos-
phorylated band ratio increased with increasing levels of pheromone, implying that a
greater proportion of the abridged Fus3-Phospholocator is phosphorylated in condi-
tions in which Fus3 is active.
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Figure 2-21: Analysis of Fus3-Phospholocator gel-shift assays. (A) Western blots using
cells from C. (B) phosphorylated:unphosphorylated band ratios as determined by dividing
the sum of the total intensities of the P2 and P1 bands by the total intensity of the PO
band.
2.2.5 Crosstalk between the Cdc28- and Fus3-Phospholoca-
tors
I tested the crosstalk between Fus3 and the Cdc28-Phospholocator, and between
Cdc28 and the Fus3-Phospholocator, in order to investigate the specificity of the
Cdc28-Phospholocator and Fus3-Phospholocator input reactions.
I compared the mean cytoplasmic:nuclear fluorescence ratios of cells expressing either
the Cdc28-Phospholocator or the Fus3-Phospholocator, arrested at either telophase or
asynchronously arrested with 1-NM-PP1 (Figure 2-22). I found that in cells arrested
in telophase, Cdc28 activity levels had no effect on the cytoplasmic:nuclear fluores-
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Figure 2-22: Analysis of Phospholocator crosstalk. Cells expressing the Cdc28- (red) or
Fus3-Phospholocator (yellow) were either arrested in telophase in the presence of 0 pM
1-NM-PP1 or 10 MM 1-NM-PP1, or asynchronously arrested with 0 AM 1-NM-PP1 in the
presence of 1 pM pheromone or 0 pM pheromone, as described in Figures 2 and 4. Error
bars show 95% confidence intervals in the estimate of the mean.
cence ratio of the Fus3-Phospholocator (Figure 2-22, bars 2 and 4). Similarly, in asyn-
chronously arrested cells, Fus3 activity levels had no effect on the cytoplasmic:nuclear
fluorescence ratio of the Cdc28-Phospholocator (Figure 2-22, bars 5 and 7). Cytoplas-
mic:nuclear fluorescence ratios of all constructs were lower in asynchronous arrests
than in telophase arrest (Figure 2-22, bars 1-4 and bars 5-8).
Each trial, taken individually, displays a similar relationship between active kinase
and average Phospholocator cytoplasmic:nuclear fluorescence ratio (Figure 2-23). I
performed a gel-shift crosstalk assay on abridged Cdc28-Phospholocator and abridged
Fus3-Phospholocator (Figure 2-24), and found that in cells arrested in telophase, high
Cdc28 activity levels caused a two-fold increase in the phosphorylated:unphosphory-
lated band ratio of the Fus3-Phospholocator compared to low Cdc28 activity levels
(Figure 2-24, bars 2 and 4); in asynchronously arrested cells, high Fus3 activity levels
caused a five-fold increase in the phosphorylated:unphosphorylated band ratio of the
Cdc28-Phospholocator (Figure 2-24, bars 5 and 7).
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Figure 2-23: Variation in crosstalk ratios across individual trials. The geometric mean of
the cytoplasmic:nuclear fluorescence ratios of cells from each of the three to five trials in
Figure 2-22, calculated using custom MATLAB scripts. The error bars show 95% confidence
intervals in the estimate of the mean.
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Figure 2-24: Analysis of crosstalk gel-shift assays. (A) A western blot of cells from Figure 2-
22. (B) phosphorylated:unphosphorylated band ratios as determined by dividing the sum
of the total intensities of the P2 and P1 bands by the total intensity of the PO band.
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Figure 2-25: The response of Cdc28-Phospholocator location to cell cycle position. (A)
Cells expressing the Cdc28-Phospholocator were arrested with pheromone for 3 hours at 30C
(first pink region), released and allowed to progress through S phase, prophase, metaphase,
and anaphase (green region) and arrested in telophase at 37C (blue region). Cells were
released from telophase and rearrested with 2 ILM pheromone (second pink region), thus
completing one full cell cycle. Cell cycle position was estimated using cellular and nuclear
morphology. An approximate schematic of predicted levels of Cdc28 activity (bound to any
cyclin) over the course of the experiment is shown by a black line [48,50]. (B) Represen-
tative images depict cell boundaries, cell nucleii, and the Cdc28-Phospholocator over time.
All YFP images were normalized together, while BF and RFP images were normalized in-
dividually. (C) The geometric mean of the cytoplasmic:nuclear fluorescence ratios across
all cells from B; error bars show 95% confidence intervals in the estimate of the mean.
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2.2.6 The Cdc28-Phospholocator as a tool for biological dis-
covery
Having determined that the Phospholocator is a useful scaffold for engineering post-
translational devices that function as designed, I next showed that Phospholocator
devices are themselves useful for studying biological systems in vivo. I used the Cdc28-
Phospholocator to measure Cdc28 activity levels in cells transitioning through a com-
plete yeast cell cycle, with arrests at G1/S phase (via the addition of pheromone),
telophase (via a temperature shift to 37 C) and again at G1/S phase. Previous re-
search has shown that Cdc28 is inactive at the G1/S transition during pheromone
arrest [64], and active during S phase and M phase [56] (Figure 2-25a). Active Cdc28
is bound to a variety of different cyclins which mediate Cdc28 substrate specificity,
and thus one might not expect that all active Cdc28-cyclin complexes will bind and
phosphorylate the Cdc28-Phospholocator. Previous research has shown that Cdc28
phosphorylates Swi5 in mitosis [57], so I expected that active Cdc28 would phospho-
rylate the Cdc28-Phospholocator during mitosis as well. Correspondingly, I expected
that the cellular distribution of Cdc28-Phospholocator would shift from primarily
nuclear during pheromone arrest to primarily cytoplasmic during telophase, before
returning to primarily nuclear during the second pheromone arrest.
I incubated SST1040 cells expressing the Cdc28-Phospholocator with pheromone
for 3 hours at 30 oC to synchronize cells at the G1/S cell cycle transition. I then
removed the pheromone and incubated the cells at 37 oC for 7 hours to arrest cells
in telophase. I released cells from telophase by shifting the temperature back to
30 C for 4.5 hours, and added 2 ILM pheromone to the media to arrest cells at
the second G1/S cell cycle transition, completing one full cell cycle. I imaged the
cells every 20 minutes to observe cell cycle progression from the G1/S transition to
telophase, and back to the G1/S transition (Figure 2-25b). I found that the mean
cytoplasmic:nuclear fluorescence ratio increased from 0.42 in the first G1/S transition
to 0.75 in telophase, before decreasing to 0.63 in the second G1/S transition (Figure 2-
25c). Given this rate of decrease in the cytoplasmic:nuclear fluorescence ratio at the
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Figure 2-26: Nuclear and cytoplasmic responses to cell cycle position. (A) Cdc28-Phospho-
locator localization was observed over the course of an entire yeast cell cycle, as described
in Figure 2-25. The mean nuclear (red) and cytoplasmic (green) fluorescence per unit area
across all cells was calculated using MATLAB scripts; error bars indicate 95% confidence
intervals in the estimate of the mean. Estimated cell cycle position is shown using the
same color scheme as in Figure 2-25. (B) Mean total nuclear (red) and cytoplasmic (green)
fluorescence levels across all cells in A. Error bars indicate 95% confidence intervals in the
estimate of the mean. (C) Mean nuclear and cytoplasmic size across all cells in A. Error
bars indicate 95% confidence intervals in the estimate of the mean. (D) Mean total cellular
fluorescence across all cells in A. Error bars indicate 95% confidence intervals in the estimate
of the mean.
second G1/S transition, I expected that the cytoplasmic:nuclear fluorescence ratio
would drop down to 0.42 again after 3-4 hours. I more closely investigated Cdc28-
Phospholocator dynamics in the cytoplasm and nucleus individually by measuring the
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mean fluorescence per unit area (Figure 2-26a), mean total fluorescence (Figure 2-
26b), and mean size (Figure 2-26c) of the cytoplasm and nucleus, as well as the
mean total cellular fluorescence (Figure 2-26d). I found that the mean size and
total fluorescence of the cytoplasm quadrupled over the course of the experiment,
while the mean cytoplasmic fluorescence increased 20% during the transition from
pheromone arrest to telophase and held relatively constant during telophase and the
second pheromone arrest. The mean size and total fluorescence of the nucleus doubled
over the course of the experiment, while the mean nuclear fluorescence decreased 25%
during the transition from pheromone arrest to telophase and increased 25% during
the transition from telophase to the second pheromone arrest. My results indicate
that the location of the Cdc28-Phospholocator appears to be cell-cycle dependent, in
a manner that is consistent with what is known about Cdc28 activity (Discussion).
2.3 Materials and Methods
2.3.1 Plasmids and strains
I built strain SST1040 from Saccharomyces cerevisiae strain TCY3043 (W303a deriva-
tive, MATa canl::HO-CAN1 ho::HO-ADE2 barl:ura3 ade2 leu2 trpl his3CDC28:CDC28-
F88A) (gift from Dr. Alejandro Colman-Lerner). I integrated a modified pRS306 vec-
tor containing a pCTS1-2xmCherry-SV4ONLS-ADH1terminator fusion (gift from Dr.
Pam Silver) into TCY3043 at the ura3 locus. I mated the resulting strain, SST1030-
1018 with strain 2597 (MATa, cdc15-2, leu2-3, ura3, trpl-1, omns) (gift from Dr.
Angelika Amon). I dissected the resulting tetrads and selected for strains with the
cdc15-2 mutation to serve as SST1040.
I built all Phospholocator constructs on pRS403 plasmids modified with the GAL1
promoter and CYCi terminator flanking the multiple cloning site [35] (gift from Dr.
Chris Kaiser). I employed recombination and cloning to assemble the Phospholocator
from the SWI5-NLS and FUS3 docking site (obtained via genomic PCR of TCY3043),
VENUS gene (Registry of Standard Biological Parts) and LACZ gene (gift from Dr.
Alejandro Colman-Lerner) (Figure 2-27). I transformed linearized vector into strains
using a high-efficiency lithium acetate protocol [37]. I verified single integration using
selective plates and genomic PCR.
2.3.2 Dose response, crosstalk, and mutant microscopy as-
says
For the telophase arrest assays, I grew cells overnight at 30 oC to a density of 0.5 - 0.7
in SCR-u-h media, I arrested cells at 37 C for three hours, sonicated for 15 seconds,
and plated for 15 minutes on a glass-bottomed 96 well plate. I had previously prepared
the plate by incubating it with 100 pl of 200 fg/ml conconavilin for >30 minutes, and
rinsing twice with water. I rinsed cells twice with SCR-u-h media, and resuspended
the cells in SCG-u-h media with varying concentrations of 1-NM-PP1 from a stock
solution of 10 mM in DMSO (gift from the Molecular Sciences Institute). I incubated
cells at 37 °C for 4:30 hours, and imaged them using an automated image acquisition
program that I wrote using iVision (Biovision Technologies), focusing on bright field
cell images. I analyzed between 50 and 1200 cells for each sample in each trial.
For the pheromone arrest assays, I grew cells overnight at 30 oC to a density
of 0.5 - 0.7 in SCR-u-h media. I sonicated overnight cell cultures for 15 seconds,
plated for 15 minutes on glass-bottomed 96 well plates treated with conconavilin as
described above, rinsed twice, and resuspended in SCG-u-h media with 10 puM 1-NM-
PP1, 20 pg/ml blocking reagent (Roche 11096176001) and varying concentrations
of pheromone (Sigma T6901) from a stock solution at 3 mM in water. I incubated
the cells at 30 oC for 2:30 hours, and then imaged using the same scripts as for the
telophase arrests.
2.3.3 Image Analysis for dose response, crosstalk, and mu-
tant assays
I developed a series of MATLAB scripts to quantify average cytoplasmic and nuclear
fluorescence levels, with background subtraction, called Cytonuc-analysis-ssutton.m
terminatororigin
cyci Terminato
venus (YFP)
venus (YFP)
C-terminusN-terminus
Swi5 P04 SwiI P04o Swi YFPNLS peptide NLS peptide NLS
DNA Sequence Protein Sequence DNA Sequence Protein Sequence
agcggtggtaaaaagtatgaaaacgtggt
Cdc28- aattaaaaggtctccaagaaaaagaggaa sggkkyenwikrsprkrgrpr
unknown unknown gaccaagaaaagatggaacttcaagtgtt kdgtssvssspikeninkdhn
tctagtagtccaatcaaagaaaatattaaca gqlmfkl
aggatcataatggacagttgatgttcaagctt
agcggtggtaaaaagtatgaaaacgtggt
S15A-Cdc28- aattaaaagggctccaagaaaaagaggaa sggkkyenwikraprkrgrpr
Phospholocator unknown unknown gaccaagaaaagatggaacttcaagtgtt kdgtssvssspikeninkdhn
tctagtagtccaatcaaagaaaatattaaca gqlmfkl
aggatcataatggacagttgatgttcaagctt
agcggtggtaaaaagtatgaaaacgtggt
S33A-Cdc28- aattaaaaggtctccaagaaaaagaggaa sggkkyenwikrsprkrgrpr
Phospholocator unknown unknown gaccaagaaaagatggaacttcaagtgtt kdgtssvssapikeninkdhn
tctagtgcaccaatcaaagaaaatattaaca gqlmfkl
aggatcataatggacagttgatgttcaagctt
agcggtggtaaaaagtatgaaaacgtggt
S15AIS33A- aattaaaagggctccaagaaaaagaggaa sggkkyenwikraprkrgrprCdc28- unknown unknown gaccaagaaaagatggaacttcaagtgtt kdgtssvssapikeninkdhnPhospholocator tctagtgcaccaatcaaagaaaatattaaca gqlmfkl
aggatcataatggacagttgatgttcaagctt
tttcaacgaaagactttacaga agcggtggtaaaaagtatgaaaacgtggt
Fus3- gaaggaacttgaaagggctca mfqrktlqrrnlk aattccacagtctccaagaaaaagaggaa sggkkyenwipqsprkrgrpr
Phospholocator atcttaacctgcacccagatgt glnlnlhpdvgn gaccaagaaaagatggaacttcaagtgtt kdgtssvpqspikeninkdhn
ccacagagtccaatcaaagaaaatattaaca gqlmfkl
aggatcataatggacagttgatgttcaagctt
Figure 2-27: The construction of the Phospholocator devices. (A) All Phospholocator
constructs were built on pRS403 plasmids modified with the GAL1 promoter and CYC1
terminator flanking the multiple cloning site. (B) DNA and protein sequences of Phospho-
locator binding peptides, phosphorylation peptides, and nuclear localization signals.
wi5 P04 SwiS P04 SwiwNLS peptide NLS peptidel NLSConstruct
(MIT DSpace DOI http://hdl.handle.net/1721.1/41534). In brief, the software de-
tects cell boundaries using bright field images that are 1.4 microns out of focus, and
detects cell nucleii using RFP images that detect nuclear 2xmCherry-SV40NLS levels
in SST1040. The software analyzes YFP images to determine the average nuclear flu-
orescence and average cytoplasmic fluorescence of each cell, and the average cellular
background fluorescence of cells not expressing YFP. The software subtracts the av-
erage background fluorescence from the average nuclear fluorescence and cytoplasmic
fluorescence of each cell, calculates the ratio of the average cytoplasmic to average
nuclear fluorescence for each cell, and outputs the geometric mean of the average
cytoplasmic:nuclear fluorescence ratio across all cells within the trial.
2.3.4 Cell-cycle response assay
I grew cells overnight to OD 600 = 0.58, and resuspended the cells in SCG-u-h with 1
pM pheromone and 20 pg/ml blocking reagent. I incubated the cells for 3 hours at
30 'C to arrest cells at the G1/S cell cycle transition. I then incubated the cells in 1
mg/ml protease type XIV (Sigma, C2010) for 20 minutes to digest pheromone, and
rinsed the cells five times with SCG-u-h. I sonicated and plated the cells on glass-
bottomed 96 well plates, as described above, and resuspended the cells in SCG-u-h.
I incubated the cells at 37 C for 7 hours to arrest cells in telophase, and imaged
the cells every 20 minutes. I then released the cells from telophase by shifting the
temperature back to 30 'C, and added 2 pM pheromone to the media. I incubated
the cells at 30 oC for 4.5 hours to arrest at the G1/S cell cycle transition. I quantified
the cytoplasmic:nuclear fluorescence ratios of the cells using the MATLAB scripts
described above.
2.3.5 Gel Shift assay
For the telophase arrest assays, I grew cells overnight at 30 'C to a density of 0.5 -
0.7 in SCR-u-h media, arrested cells at 37 C for three hours, and then resuspended
in SCG-u-h media with varying concentrations of 1-NM-PP1 from a stock solution
of 10 mM in DMSO. I incubated cells at 37 °C for 4:30 hours, pelleted and aspirated
OD 600 = 0.6 of the cells, and flash froze the cell pellets in liquid nitrogen. I resus-
pended the pellets in 150 /~ of 1.85 M NaOH and 7.4% 2-mercaptoethanol, vortexed,
incubated 10 minutes on ice, and added 150 /A of ice-cold 50% TCA. I incubated the
solution for an additional 10 minutes on ice, centrifuged for two minutes at 4 C, re-
moved the supernatant, and resuspended in 1 ml of acetone. I centrifuged, aspirated,
dried the pellets, and resuspended in 25 pl sample buffer (2 ml 4X Tris-Cl/SDS, pH
8.8, 6 ml 40% glycerol, 0.8 g SDS, 0.31 g DTT, 2 mg Coomassie blue G-250 to 10
ml with MilliQ water). I boiled the samples for five minutes, vortexed, and loaded
the entire sample on a 16 cm x 37 cm 12% SDS-PAGE gel (CBS Scientific). I ran
the gel at 400 V at 4 C for 120 hours, blotted with anti-GFP antibody (gift from
Dr. Robert Sauer) and an alkaline phosphatase linked secondary antibody from the
Enzyme Catalyzed Fluorescence (ECF) western blotting Reagent Pack (Amersham
Biosciences, RPN5783). I incubated the blot with ECF substrate, imaged the fluo-
rescence of modified ECF substrate on the Typhoon 9400 Variable Mode Imager (GE
Healthcare), and quantified bands using Image Quant (GE Healthcare) by measur-
ing the total intensity of each band and subtracting background lane measurements.
For the pheromone arrest assays, I grew cells overnight at 30 'C to a density of 0.5
- 0.7 in SCR-u-h media. I resuspended cells in SCG-u-h media with 10 PM 1-NM-
PP1, 20 pg/ml blocking reagent (Roche 11096176001) and varying concentrations of
pheromone (Sigma T6901) from a stock solution at 3 mM in water. I incubated the
cells at 30 'C for 2:30 hours, pelleted and aspirated OD 600 = 0.6 of the cells, and flash
froze the cell pellets in liquid nitrogen. I extracted protein, ran the extracts on a
large-format SDS-PAGE gel and imaged as described above for the telophase assays.
2.4 Discussion
2.4.1 Two translocating post-translational devices that func-
tion as designed
I developed a framework for engineering post-translational devices. Within this frame-
work, a post-translational device is decomposed into a set of coupled input and output
reactions. The input reactions convert the device input signal to a change in internal
device state, while the output reactions convert the change in internal device state to
an output signal. Examples of input and output signals for post-translational devices
are kinase activity (that is, the concentration and catalytic activity of an active kinase)
and nuclear translocation (defined as the remaining concentration of a protein in the
cytoplasm), among others. To evaluate my engineering framework I developed a pro-
tein scaffold, the Phospholocator, that is designed to support the coupling of multiple
input reactions to a common set of output reactions. I demonstrated the utility of
the Phospholocator scaffold by constructing and testing two instances of Phospholo-
cator devices: the Cdc28-Phospholocator and the Fus3-Phospholocator. Steady-state
measurements confirmed that the Cdc28-Phospholocator and Fus3-Phospholocator
devices are responsive to the Cdc28 inhibitor 1-NM-PP1 and to yeast pheromone,
respectively. I showed that Cdc28 likely regulates the location of the Cdc28-Phos-
pholocator by phosphorylating two serines within the Phospholocator NLS, S15 and
S33. Likewise, Fus3 likely regulates the location of the Fus3-Phospholocator by phos-
phorylating S15 and S33. My results show that the effects of the phosphorylated
serines are additive, and thus I expected that I might be able to tune the affinity of
the interaction between the nuclear import machinery and the Cdc28-Phospholocator
by adjusting the number of phosphorylated serines within the Phospholocator NLS.
2.4.2 Differences between the abridged and full-length Phos-
pholocators
I performed gel shift assays on wild-type and mutant versions of the Phospholocator
in order to provide more direct evidence of phosphorylation. In making these mea-
surements, I used abridged versions of the Phospholocators that lack a 0-galactosidase
domain. Because I hoped to make quantitative comparisons across micrograph and
gel shift experiments, I felt that it was important to consider if the expected behavior
of abridged Phospholocators might differ from that of full-length Phospholocators. I
noted four factors that might impact whether or not data obtained using abridged
Phospholocators would be representative of the phosphorylation states of full-length
Phospholocators: (i) differences in levels of expression, (ii) differences in cellular lo-
calization, (iii) differences in protein folding, and (iv) differences in protein-protein in-
teractions. To evaluate the first factor, I tested the rates of expression of the abridged
and full-length Cdc28-Phospholocators and found that cells expressing the abridged
Cdc28-Phospholocator fluoresced 2.5 times more brightly than cells expressing the
full-length Cdc28-Phospholocator (Figure 2-28a and b).
Different cellular levels of abridged and full-length Cdc28-Phospholocator could re-
sult in different phosphorylation kinetics, and hence different phosphorylated:unphos-
phorylated band ratios for the abridged and full-length Cdc28-Phospholocators. To
evaluate the second factor, I tested the localization of the abridged and full-length
Cdc28-Phospholocator, and found that cells expressing the abridged Cdc28-Phospho-
locator exhibit higher mean cytoplasmic:nuclear fluorescence ratios than cells express-
ing the full-length Cdc28-Phospholocator (Figure 2-28a and c), most likely because
the abridged Cdc28-Phospholocator more quickly moves through nuclear pores given
its smaller mass. This quantitative difference in cellular localization may cause differ-
ences in the phosphorylated:unphosphorylated ratios for the abridged and full-length
Phospholocators because Cdc28 and Fus3 are more highly concentrated in the nucleus
than in the cytoplasm [77, 46, 47, 55, 80, 84, 88]. To evaluate the third factor, I noted
that both the abridged and full-length Phospholocators fluoresce (Figure 2-28a), sug-
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Figure 2-28: Differences in cells expressing the abridged and full-length Cdc28-Phospho-
locator. (A) SST1040 cells expressing the abridged or full-length Cdc28-Phospholocator
were arrested with 1 pM pheromone and 10 pM 1-NM-PP1 for 2.5 hours as in Figure 2-
22. Representative images depict cell boundaries (bright field), cell nucleii (RFP filter),
and the Cdc28-Phospholocator (YFP filter). All YFP images were normalized together,
while BF and RFP images were normalized individually. (B) The mean total cellular
fluorescence across all cells in A was calculated using MATLAB scripts; error bars indicate
95% confidence intervals in the estimate of the mean. (C) The geometric mean of the
cytoplasmic:nuclear fluorescence ratios of all cells from A. Error bars show 95% confidence
intervals in the estimate of the mean.
gesting that, because protein folding is primarily influenced by neighboring residues
[39], all parts that are N-terminal to the YFP domain likely also fold similarly in the
abridged and full-length Phospholocators. Finally, in considering the fourth factor, I
noted that there is no published evidence that 3-galactosidase either binds or does not
bind Cdc28 or Fus3. Thus, 3-galactosidase may or may not contribute to the affinity
between Cdc28 or Fus3 and the Phospholocators. Despite these possible factors, the
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quantitative gel band ratios of abridged Phospholocators (Figure 2-11, and 2-21)
are well-correlated with the analogous cellular fluorescence localization ratios that I
observed using full-length Phospholocators (Figure 2-5, 2-6, 2-16, 2-17), across ex-
periments using the wild-type phosphorylation peptides and also each of the phospho-
defective point mutants (Figure 2-12 and 2-13). Interestingly, the gel shift data show
a greater absolute difference, or swing, in Phospholocator state between high and low
kinase activity levels than do the micrograph data; for example, the mean cytoplas-
mic:nuclear fluorescence ratio of the full-length Cdc28-Phospholocator varies between
0.52 and 0.72 in all conditions tested, while the phosphorylated:unphosphorylated
band ratio of the abridged Cdc28-Phospholocator varies between 0.5 and 4.5. Under-
standing these differences in swing could yield insights into the intracellular dynamics
and activities of the translocation machinery, Cdc28, or Fus3; doing so would likely
require direct methods for measuring phosphorylated full-length Phospholocator and
the interaction between the Phospholocator and the nuclear translocation machin-
ery. To directly measure phosphorylated full-length Phospholocator, one could either
(i) engineer a protease cleavage site between the YFP and 0-galactosidase moieties
of the Phospholocator, and cleave the Phospholocator after extraction and before
running extracts on a gel, or (ii) perform autoradiography on immunoprecipitated
Phospholocator from cells grown in the presence of radioactive phosphorus.
2.4.3 Nuclear bias of the Phospholocators
Cell micrographs showed that even when Cdc28 and Fus3 are highly active, the full-
length Cdc28-Phospholocator and full-length Fus3-Phospholocator are predominantly
nuclear, as indicated by mean cytoplasmic:nuclear fluorescence ratios of less than one.
I suggest two reasons for the preponderance of nuclear Phospholocator. First, phos-
phorylated Phospholocator may still bind nuclear import machinery, albeit at a lower
affinity than unphosphorylated Phospholocator. Second, Cdc28 and Fus3 compete
with the import machinery for newly synthesized Phospholocator proteins, and thus
some Phospholocator molecules are likely bound by the import machinery and trans-
ported into the nucleus before Cdc28 or Fus3 are able to phosphorylate individual
Phospholocator molecules. Once a Phospholocator molecule has been imported into
the nucleus, it likely leaves the nucleus at a slow rate, due to its large size (155 kDa).
Nuclear-localized Phospholocator can be phosphorylated by Cdc28 or Fus3, as both
active Cdc28 and Fus3 are located in the nucleus [77, 14, 21, 27, 38, 42, 52]. Thus,
while one might expect the majority of cytoplasmic Phospholocator molecules to be
phosphorylated, it is likely that the nuclear population of the Phospholocator consists
of both phosphorylated and unphosphorylated Phospholocator. To test the phospho-
rylation state of the nuclear Phospholocator population, one could fractionate cells,
isolate the nucleii, and perform a gel-shift assay on nuclear lysates; however, the tech-
nologies necessary for reliable yeast nuclear fractionation have not yet been developed
[Dr. Pam Silver, personal communication].
2.4.4 Lack of crosstalk between the Cdc28- and Fus3-Phos-
pholocators
The phosphorylation peptides of the Cdc28-Phospholocator and Fus3-Phospholocator
differ by only two residues per peptide, and the Fus3-Phospholocator contains not only
the Fus3 docking peptide, but also potentially an unidentified Cdc28 docking peptide.
Given this, it seemed possible that Cdc28 might phosphorylate the Fus3-Phospholo-
cator, and vice-versa. Thus, I tested the ability of Phospholocator input reactions
to interface with the right and wrong input signals to understand if the Cdc28-Phos-
pholocator will independently respond to active Cdc28 in conditions of high Fus3
activity, and if the Fus3-Phospholocator will independently respond to active Fus3
in conditions of high Cdc28 activity. I also hoped to compare how one input signal
interacts with two different sets of input reactions, so that I could learn more about the
contributions of the docking peptide and phosphorylation peptides to the specificity
of a target kinase for its cognate Phospholocator. I tested the crosstalk between Fus3
and the Cdc28-Phospholocator, and between Cdc28 and the Fus3-Phospholocator,
and micrograph data showed no crosstalk: Cdc28 activity levels had no effect on
Fus3-Phospholocator translocation, and Fus3 activity levels had no effect on Cdc28-
Phospholocator translocation. Gel shift assays showed slight crosstalk: high Cdc28
activity levels caused a two-fold increase in the phosphorylated:unphosphorylated
band ratio of the Fus3-Phospholocator compared to conditions of low Cdc28-activity,
while high Fus3 activity levels caused five-fold increase in phosphorylated:unphos-
phorylated band ratio of the Cdc28-Phospholocator. However, the crosstalk seen in
the gel shift assays is modest compared to the effect of active Cdc28 and Fus3 on the
phosphorylated:unphosphorylated band ratio of their cognate Phospholocators; high
Cdc28 activity levels caused a ten-fold increase in phosphorylated:unphosphorylated
band ratio of the Cdc28-Phospholocator compared to conditions of low Cdc28-activity,
while high Fus3 activity levels caused 20-fold increase in phosphorylated:unphosphor-
ylated band ratio of the Fus3-Phospholocator. I conclude that there is little crosstalk
between Cdc28 and Fus3 and the Fus3-Phospholocator and Cdc28-Phospholocator,
respectively, and thus the small compositional differences between the two Phospho-
locators causes large specificity differences.
Our crosstalk micrograph data also shows that cell cycle position appears to
greatly influence full-length Phospholocator location, as the cytoplasmic:nuclear fluo-
rescence ratios of all constructs were lower in asynchronous arrests than in telophase
arrest. This result is not surprising, given that asynchronous arrest and telophase
arrest represent two very different cell states. However, the gel shift data does not
show a similar correlation between cell cycle position and Phospholocator phosphor-
ylated:unphosphorylated band ratio, thus implying that either the abridged and full-
length Phospholocator constructs respond differently to cell state, or that the output
reaction itself (nuclear translocation) is greatly influenced by cell state.
2.4.5 Additional Phospholocator characterizations
In my experimental work, I report the input signals of the Phospholocator as concen-
trations of 1-NM-PP1 or pheromone, and the output signals as cytoplasmic:nuclear
fluorescence ratios. Such first-order signals are easy to control and measure and
thus are appropriate for designing and testing new post-translational device scaffolds.
However, as more post-translational devices are built, I would instead prefer to re-
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Figure 2-29: Characterization of Phospholocator output reactions. The correlation be-
tween the phosphorylated:unphosphorylated band ratio and mean cytoplasmic:nuclear fluo-
rescence ratio of the Cdc28-Phospholocator (red) and Fus3-Phospholocator (green) is shown
for each concentration of 1-NM-PP1 in Figure 2-6b and each concentration of pheromone in
Figure 2-17b; this correlation characterizes the output reactions. These characterizations
can not be taken as accurate quantitative responses because the phosphorylated:unphos-
phorylated band ratio and cytoplasmic:nuclear fluorescence ratio were measured on two
different constructs, the abridged Phospholocator and the full-length Phospholocator, re-
spectively.
port input signals as concentrations and activities of Cdc28 and Fus3 directly, and
output signals as concentrations of cytoplasmic Phospholocator (Figure 2-3), since
such signals could more directly interface with other post-translational devices. For
example, by characterizing the input signal to the Cdc28-Phospholocator in terms of
the concentration of 1-NM-PP1, one could only connect the Cdc28-Phospholocator
to upstream devices that produce 1-NM-PP1 as an output signal; such devices do not
currently exist, as 1-NM-PP1 is a synthetic chemical of non-biological origin.
In addition to combining post-translational devices to build systems, one would
A
also like to combine sets of input and output reactions to build new devices. To do
so, one must characterize each set of input and output reactions separately so that
(i) one can determine if input and output reactions are compatible, and (ii) one can
predict the behavior of different combinations of input and output reactions. The
gel shift data characterizes the input reactions of the Phospholocator since it gives
the correlation between the input signal and the change in internal device state, the
level of phosphorylated abridged Phospholocator. The micrograph data characterizes
the entire Phospholocator since it gives the correlation between the input and output
signals. One could, in theory, characterize the output reactions of the Phospholoca-
tor by comparing Phospholocator phosphorylation driven by the input reactions with
the nuclear translocation of the entire Phospholocator (for example, Figure 2-29).
However, it is important to recognize that the output reactions so-estimated can not
be taken as accurate quantitative descriptions because the phosphorylated:unphos-
phorylated band ratio measurements (x-axis) and cytoplasmic:nuclear fluorescence
ratio measurements (y-axis) were made using two different constructs, the abridged
Phospholocator and the full-length Phospholocator, respectively.
One of the potential advantages of post-translational devices over transcriptional
devices is a shorter time requirement to switch states. For example, the transcrip-
tional ring oscillator built by Elowitz et al. transitions from low fluorescence to
high fluorescence in 50 minutes [30]. As another example, the transcriptional toggle
switch built by Gardner et al. switches states in 300 minutes, although this time
delay could be decreased to 60 minutes if the difference between high and low states,
the "swing" of the switch, were decreased by half [36]. The experimental set-up
I developed does not let me easily determine how quickly the the Phospholocator
location adjusts to changes in activity levels of input kinases, because the Phospho-
locator is continuously expressed in the cytoplasm throughout my experiments. We
can estimate approximate rates of Phospholocator phosphorylation and translocation
using previously published rates of MAP kinase activation and protein translocation.
Yu et al. demonstrated that 50% of the 20,000 Fus3 molecules per yeast cell were
activated 2.5 minutes after the addition of pheromone [94]; Fus3 activation requires
signal propagation through a multi-component signaling cascade, and thus individual
kinase phosphorylation reactions likely occur within tens of seconds. Efthymiadis et
al. demonstrated that the nuclear:cytoplasmic ratio of 0-galactosidase fused to the
retinoblastoma bipartite NLS and injected into mammalian cells changed at a rate
of 0.49 per minute [29]. Thus, it seems likely that Phospholocator location would
respond to changes in input kinase activity levels over the course of a few minutes.
In order to measure the exact rates of Phospholocator import in response to differing
levels of input kinase activity, researchers could employ the technique of fluorescence
recovery after photobleaching (FRAP), in which researchers photobleach the nucleii
of yeast cells, and observe the rate at which nuclear fluorescence levels recover.
2.4.6 The Cdc28-Phospholocator as a biological tool
I wanted to learn if the Cdc28-Phospholocator could serve as a useful genetically-
encoded indicator of Cdc28 activity levels, and devised an experiment to observe
Cdc28-Phospholocator location over the course of a cell cycle. In designing this ex-
periment, I was concerned that multiple factors might convolute my interpretations of
the cell-cycle measurements. First, in testing the Cdc28-Phospholocator, I observed
a time delay, or latency, between a change in Phospholocator input signal and the es-
tablishment of a steady-state Phospholocator output signal (Figure S8). Second, both
cytoplasmic and nuclear volumes change over the course of a cell cycle; because my
measurements are based on Phospholocator concentrations, changing volumes could
affect the cytoplasmic:nuclear fluorescence ratio measured. Third, the basal cytoplas-
mic:nuclear fluorescence ratio fluorescence ratio in the absence of Cdc28 activity may
be different in pheromone arrest than in telophase (Figure 2-22).
I avoided issues of latency by arresting cells at the G1/S transition and telophase
instead of allowing cells to progress through the cell cycle at normal rates. I ob-
served that when the cells first entered telophase, at approximately 200 minutes after
pheromone release, the mean cytoplasmic:nuclear fluorescence ratio had risen to 0.61
from 0.42 at 80 minutes post pheromone release. After 260 minutes in telophase (460
minutes after pheromone release), the mean cytoplasmic:nuclear fluorescence ratio
had risen to 0.75. Thus, the magnitude of the mean cytoplasmic:nuclear fluores-
cence ratio was dependent on the length of time the cells spent in telophase. Phos-
pholocator latency is likely influenced by five factors: (i) the rate at which nuclear
Cdc28-Phospholocator molecules move through the nuclear pores, either via diffusion
or export, (ii) the rate at which cytoplasmic Cdc28-Phospholocator is actively im-
ported into the nucleus, (iii) the rate at which new Cdc28-Phospholocator molecules
are synthesized in the cytoplasm, (iv) the rate at which Cdc28 phosphorylates the
Cdc28-Phospholocator, and (v) the rate at which phosphatases dephosphorylate the
Cdc28-Phospholocator.
I accounted for changing cytoplasmic and nuclear volumes by monitoring the
mean cross-sectional area and fluorescence of the cytoplasm and nucleus individually
(Figure 2-26). I found that the mean area and total fluorescence of the cytoplasm
quadrupled over the course of the experiment, but the mean fluorescence per unit
area of the cytoplasm changed very little during telophase and the second pheromone
arrest. The mean area and total fluorescence of the nucleus doubled over the course
of the experiment, and the mean nuclear fluorescence per unit area decreased in
telophase and increased at the transition from telophase to the second pheromone
arrest. The changes in cytoplasmic:nuclear fluorescence ratio across the cell cycle
thus appear to be largely due to changes in the levels of nuclear Phospholocator.
This result is not surprising given that the volume of the nucleus is approximately
5% that of the cytoplasm [46, 47, 55, 80, 84, 88, 75], and thus small changes in
cytoplasmic Phospholocator concentration can give rise to large changes in nuclear
Phospholocator concentration; for example, if 5% of the cytoplasmic Phospholocator
translocates into the nucleus, the nuclear concentration of Phospholocator increases
by approximately 100%.
I accounted for cell-cycle-dependent changes in the basal cytoplasmic:nuclear fluo-
rescence ratios by comparing the results of my cell cycle assay to my crosstalk results.
My crosstalk results suggest that the basal level of the Cdc28-Phospholocator cyto-
plasmic:nuclear fluorescence ratio is higher in telophase than in pheromone arrest,
regardless of Cdc28 activity. However, the cytoplasmic:nuclear fluorescence ratios I
observed 4.5 hours into telophase in the cell cycle assay (0.75) exceeded basal levels
observed 4.5 hours into telophase in the crosstalk assay (0.6), and thus I conclude
that the rise in Cdc28-Phospholocator cytoplasmic:nuclear fluorescence ratio during
telophase is due at least partly to Cdc28 activity. Having addressed the three possibly
confounding factors in the cell cycle assay, I conclude that the Cdc28-Phospholocator
can be used to observe Cdc28 activity levels in vivo at different stages of the yeast
cell cycle, as the temporal progression of Cdc28-Phospholocator location appears well
matched to what is known about Cdc28 activity throughout the cell cycle. In order
to use the Cdc28-Phospholocator to make real time measurements of Cdc28 activity
levels in cells, researchers would need to more fully understand or remove the causes
of Cdc28-Phospholocator latency.

Chapter 3
Definition of a universal
post-translational signal carrier
3.1 Introduction
In the previous chapter, I developed a first-generation framework for designing and
building functional post-translational devices. Individual post-translational devices
can be used to couple one existing cellular system with another; for example, the
Fus3-Phospholocator couples the pheromone response pathway to the nuclear import
machinery. By fusing a transcription factor onto the Fus3-Phospholocator, one could
likewise couple the pheromone response pathway to gene expression. To take full ad-
vantage of post-translation devices, however, post-translational device engineers must
move beyond single devices that interface with existing cellular systems and construct
multi-device systems that are more isolated from existing cellular machinery, for sev-
eral reasons. First, multi-device systems can perform more complex functions than
single devices can alone. Second, existing cellular systems display a limited range of
functions, evolved for the purpose of survival and not necessarily for purposes that
humans would deem useful. Thus, engineers can implement a greater range of func-
tions by building new systems than by relying on existing cellular systems. Third,
existing systems often have complex architectures that impact device function. For
example, active Fus3 causes an upregulation in the expression of several proteins in
the pheromone response pathway, including Fus3 [26]. This feedback makes it difficult
for researchers to precisely control and predict the input to the Fus3-Phospholocator.
By engineering new multi-device systems instead of relying on complicated existing
systems, engineers can more precisely control system inputs and behavior.
Given the expected utility of building many more post-translational devices and
also multi-device systems, I explored the challenges inherent in connecting post-
translational devices with each other, and designed methods to overcome these chal-
lenges. I again looked to other engineering disciplines to learn about design principles
for combining devices to form systems. For example, in electrical engineering, devices
are designed so that they can be connected with all other devices within a common
"device family." There are two important aspects of device-device interconnectivity
within a device family: (i) all devices must accept and provide signals via a com-
mon signal carrier, and (ii) device signals must not extend beyond a specified range
of levels. For example, electrical signal carriers consist of voltage and current, and
typical signal ranges are + 100 mA and ± 5V for devices in the transistor-transistor
logic (TTL) device family. A given TTL device can interface with any other TTL
device that accepts as input and emits as output the common signal carrier at these
appropriate levels. Widespread device compatibility allows engineers to build a com-
binatorial number of ordered systems; for example, given only five compatible TTL
devices, an engineer can build as many as 25 distinct two-device systems, 125 distinct
three-device systems, 625 four-device systems, et cetera. In order to help achieve
similar degrees of post-translational device interconnectivity, then, I sought to define
a common signal carrier for post-translational devices. Post-translational devices dif-
fer from electrical devices in that electrical devices are statically connected by a wire
that mediates the flow of electrons between devices; post-translational devices, on
the other hand, are transiently connected via sets of interacting binding domains and
peptides. Unintended crosstalk between electrical devices can occur via the magnetic
fields produced by changes in current flow along a wire, whereas crosstalk between
post-translational devices can occur via non-specific protein-protein binding. Once
researchers have learned how to design and build devices using the common signal
carrier, researchers can begin to specify common ranges of signal levels for post-
translational device families.
3.2 Results
3.2.1 Two possible models for post-translational device com-
position
I explored the challenge of defining a standard signal carrier for post-translational
devices by considering a simple system consisting of three kinases that interact in
series (Figure 3-1). The first kinase (Figure 3-1, green) binds and phosphorylates the
second kinase (Figure 3-1, orange), thereby activating the second kinase. The second
kinase, when active, binds and phosphorylates the third kinase (Figure 3-1, pink),
thereby activating the third kinase.
In exploring the signals passed between the three kinases, I determined that the
device signal carrier is dependent upon the definition of a device itself. For example,
a physically intuitive device definition would consist of each kinase being defined as
a separate device (Figure 3-2a). I call this model for device composition the "specific
signal" (SS) model. The output signal of device 1 (Figure 3-2, green) is the activity
of the first kinase, which targets substrates that display binding peptides (Figure 3-2,
triangle) and phosphorylation peptides (Figure 3-2, oval) that can bind the first ki-
nase. Likewise, the output signal of device 2 (Figure 3-2, orange) is thus the activity
of the second kinase, which targets substrates that display binding peptides and phos-
phorylation peptides that can bind the second kinase. As described in the previous
chapter, I noted that the activity of each kinase can be described by two separate
components: (i) the concentration of active kinase, and (ii) the catalytic activity (kat)
of the active kinase. Electrical systems also employ two signal components, current
and voltage. For clarity, it is important to note that we do not consider kinase con-
centration and catalytic activity to be direct analogs of voltage and current. The two
components of kinase activity could be multiplied together to give an input signal of
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Figure 3-1: Three kinases that interact in series. The first kinase (green) binds andphosphorylates the second kinase (orange), thereby activating the second kinase. The secondkinase, when active, binds and phosphorylates the third kinase (pink), thereby activating
the third kinase. Phosphate groups are shown as stars.
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Figure 3-2: Devices defined using the physically intuitive "specific signals" model for device
composition. (A) Device 1 (green) is defined as the first kinase, device 2 (orange) is defined
as the second kinase, and device 3 (pink) is defined as the third kinase. The signal passed
from device 1 to device 2 is the activity of the first kinase, which targets substrates displaying
cognate binding (triangle) and phosphorylation (oval) peptides. Likewise, the signal passed
from device 2 to device 3 is the activity of the second kinase, which targets substrates
displaying cognate binding (square) and phosphorylation (oval) peptides. (B) Due to the
innate substrate specificity of the first and second kinases, we could not switch the order of
devices 2 and 3 and still produce a functioning device.
the Vmax of the kinase. However, it is advantageous to define device signals in terms
of concentration and catalytic activity separately so that engineers can model device
dynamics, just as electrical engineers define current and voltage separately instead of
multiplying them together to give a signal of power. Thus, I chose to define the input
and output signals of post-translational devices designed using the SS model to be
two-component signals.
A drawback of the SS model is that this device model does not allow for full device-
device connectivity. An upstream device can only interface with a downstream device
that displays compatible docking and phosphorylation peptides; for example, device 1
can only be connected to downstream devices that display triangular binding peptides
and oval phosphorylation peptides. We could not, for example, switch the order of
device 2 and device 3 and still produce a functioning system (Figure 3-2b). Device
1 cannot interact with device 3, because device 3 does not display peptides that are
compatible with the corresponding binding domains of device 1; likewise, device 3
cannot interact with device 2 because device 2 does not display peptides that are
compatible with the corresponding binding domains of device 3. Such constraints on
device coupling drastically limit the number of post-translational systems that could
be built from a set of devices; for example, given five post-translational devices that
each accept a different input kinase, as in Figure 3-2, an engineer can only build four
two-device systems, three three-device systems, and two four-device systems. The
constraints on device compatibility arise from the fact that cognate domains and
peptides are separated into different devices.
3.2.2 A universal signal carrier for post-translational devices
To allow for greater device coupling, I designed a second model for device composition
in which device boundaries are shifted relative to the SS model, called the "universal
signal" (US) model (Figure 3-3a). In the US model, a device is defined as (i) a
kinase that lacks substrate specificity, and (ii) a binding domain and its cognate
binding peptide. The binding peptide is fused to the kinase within the device, and
the binding domain is fused to the kinase within the upstream device, thus allowing
the kinase within the upstream device to bind and phosphorylate the kinase within the
device. For example, in Figure 3-3a, device 2 (orange) consists of the second kinase,
which lacks a substrate binding domain (pink pinchers) and is fused to a binding
peptide (orange triangle) that binds the binding domain also contained within device
2 (orange pinchers). The binding domain of device 2 is fused to whichever kinase is
contained within the device connected upstream of device 2; in this case, the binding
domain of device 2 is fused to the kinase of device 1 (green). Likewise, device 3 (pink)
consists of the third kinase, which lacks a substrate binding domain and is fused to a
binding peptide (pink square) that binds the binding domain also contained within
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Figure 3-3: Devices defined using the "universal signals" model for device composition.(A) Device 2 (orange) consists of the second kinase, which lacks a substrate binding domain(pink pinchers) and is fused to a binding peptide (orange triangle) that binds the binding
domain also contained within device 2 (orange pinchers). The binding domain of device 2 is
fused to the kinase of device 1 (green). Device 3 (pink) consists of the third kinase, which
lacks a substrate binding domain and is fused to a binding peptide (pink square) that binds
the binding domain also contained within device 3 (pink pinchers). The binding domain of
device 3 is fused to the kinase of device 2 (orange). (B) Due to the innate lack of substrate
specificity of the first and second kinases, we could switch the order of devices 2 and 3 and
still produce a functioning device.
a
device 3 (pink pinchers). The binding domain of device 3 is fused to the kinase
of device 2 (orange). A key aspect of the US model is that all protein parts that
determine specificity, such as binding domains and binding peptides, are contained
within the same device as opposed to being split across devices as in the SS model.
The signals passed between devices in the US model are thus signals of kinase activity
that lack substrate specificity; specificity is determined by the downstream device into
which the signal is fed. Because the signals themselves lack substrate specificity, the
signals can serve as input to all other kinase-based devices and thus are universal.
The universal signal of kinase activity can be described by two components: (i) the
concentration of active kinase, which has no inherent substrate specificity and (ii) the
catalytic activity (kt) of the active kinase.
Physically, all kinases have the same structure, the same domains, the same speci-
ficity, and the same catalytic activity in the US model as they have in the SS model.
In building a string of interacting kinases (Figure 3-1), a researcher would physically
assemble the same kinases regardless of the device model with which the system was
designed. The main difference between devices designed using the SS model (Fig-
ure 3-2a) and the US model (Figure 3-3a), then, is that device signals in the SS
model have an implicit substrate specificity whereas device signals in the US model
do not. For example, the input into SS device 2 is the activity of the kinase contained
within device 1 (Figure 3-2a, green), which is specifically directed at the kinase con-
tained within device 2 (Figure 3-2a, orange) by the docking domain fused to the first
kinase (Figure 3-2a, green pincher-like shape). In contrast, the input into US device
2 is the output kinase activity of device 1, which has no inherent substrate specificity.
The output activity of device 1 is directed at whatever kinase is contained within
device 2. The output activity is made specific for the kinase within device 2 via the
docking domain contained within device 2 (Figure 3-3a, orange pincher-like shape)
that is fused to the kinase contained within device 1 once the output signal of device
1 is connected as input into device 2. The US model is advantageous compared to
the SS model because the signal of kinase activity that lacks substrate specificity can
be used as the input to any phosphorylation-mediated post-translational device, and
Device I Device 2 Device 3
Figure 3-4: A universal phosphorylation peptide. To ensure that all signals of catalytic
activity are universal, all post-translational devices within a device family should contain
the same phosphorylation peptide, called the "universal phosphorylation peptide" (white
ovals).
thus one could switch the order of device 2 and device 3 and still produce a function-
ing system (Figure 3-3b). The US model thus allows researchers to readily combine n
post-translational devices to build nm post-translational systems of m devices. The
ability to connect devices in new orders arises from the fact that cognate domains and
peptides are included within the same device. In order to build a model for device
composition that allows a universal signal carrier, however, I faced the trade-off of
defining devices in a way that is less physically intuitive than that of devices defined
with a non-universal signal carrier; SS devices are conceptually more intuitive than
US devices, as they consist of a protein kinase in its entirety as opposed to a collection
of protein parts from different protein kinases.
3.2.3 A set of specifications for implementing the universal
signal model for device composition
Given the advantages of the US model for device composition, I decided to develop
a set of specifications for engineering post-translational devices to be used in the US
model. These specifications would inform future post-translational device engineers
about how to select and design kinases and substrates to be used in post-translational
devices, and how to define and characterize devices such that they can be readily
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Figure 3-5: A prototypical kinase to be used in post-translational devices. We can develop
a prototypical kinase that serves as a template from which to build many derivative kinases.
reused in new combinations. I faced two main challenges in developing a set of US
model specifications. First, the output signal of a device, such as device 1 (Figure 3-
3), must be the same regardless of the device that is connected downstream of device
1, otherwise the catalytic activity would become substrate-dependent and hence not
a universal signal. The catalytic activity of a protein kinase is dependent on both
the catalytic core of the protein kinase and on the substrate phosphorylation peptide
that receives the phosphate group. The phosphorylation peptide is contained with
the device downstream of device 1, and thus the signal of kinase activity output from
device 1 depends, in part, on the device downstream of device 1. To solve this prob-
lem, I propose that all post-translational devices feature the same phosphorylation
peptide, called the "universal phosphorylation peptide" (Figure 3-4). The universal
phosphorylation peptide is not a "holy grail" peptide to be sought, as the name might
imply, but rather a peptide that is designed to be bound and phosphorylated by the
kinases used within the post-translational device family that we engineer.
The second challenge that I faced in developing a set of US model specifications
is that the US model requires that kinase substrate specificity be modular; in other
words, one must engineer kinases that lack substrate specificity, but that can be made
specific by fusing modular binding domains to the kinase. I decided to specify that
all devices built using the US model employ the same kinase, called the "prototypical
kinase" (Figure 3-5). The prototypical kinase would serve as a template from which
to engineer many derivative kinases with different catalytic activities. Upon serving
as an input kinase into a downstream device, each derivative kinase would be fused
to a binding domain specific to the device itself. The advantage of defining a proto-
typical kinase is that I can then design a set of specifications for devices using the
prototypical kinase, and post-translational device engineers can use those specifica-
tions to develop a well-defined device family in which all devices should be able to
functionally connect with all other devices within the device family. The sequence of
the universal phosphorylation peptide would be largely determined by the choice of
prototypical kinase.
I identified four criteria that are important in choosing a prototypical kinase. First,
the kinase should be well-studied, and the structural mechanisms of kinase specificity
and catalytic activity known. Second, the kinase should employ the double peptide
mechanism of substrate recognition, described in Chapter 2, because the double pep-
tide mechanism allows engineers to separate the engineering of the binding peptide
from the engineering of the phosphorylation peptide, thereby providing greater mod-
ularity in design. Third, engineers should be able to activate or inhibit the kinase via
an extracellular stimulus so that they can easily control kinase catalytic activity while
building and debugging devices. Fourth, the kinase should fold and function properly
even when (i) binding domains and peptides are fused to the termini of the kinase,
and (ii) the kinase has been mutated to eliminate innate substrate specificity. Given
this set of four criteria, I chose my prototypical kinase to be the mitogen-activated
protein kinase (MAP kinase) Fus3, because Fus3 employs the double peptide mecha-
nism of substrate binding [7], and can be activated in yeast via pheromone [92]. Fus3
is well-studied and the structure and function of Erk2, the mammalian homolog of
Fus3 [7], has also been extensively studied. To my knowledge, researchers have not
fused binding domains to the termini of Fus3, so a first step in testing devices built
using the US model would be to test if Fus3 can fold and function when domains are
fused to its termini. Tanoue et al. mutated a region of Erk2 that mediates substrate
specificity, called the common docking (CD) domain (discussed in greater detail be-
low), and showed that the mutant Erk2 bound new substrates and was catalytically
active [82]. Thus, it seems likely that the common docking domain of Fus3 can be
similarly mutated and Fus3 retain catalytic activity.
To learn how to engineer substrate recognition and catalytic activity of the Fus3
prototypical kinase, I explored the existing body of knowledge about the relationship
between Erk2 structure and function. Erk2 is activated upon the phosphorylation and
subsequent conformational change of the MAP kinase phosphorylation loop (Figure 3-
6, blue) at residues Thr183 and Tyr185 [63, 67]. Erk2 binds substrate binding peptides
via a docking domain, called the CD domain, that is comprised of an acidic cluster
located on a loop at the back of the Erk2 catalytic site (Figure 3-6, pink) [70, 81].
Erk2 binds substrate phosphorylation peptides via two separate domains: (i) the
extended peptide substrate binding groove (EPSB groove), which is likely located on
loop L13 between helixes F and G, near the base of the Erk2 catalytic site (Figure 3-
6, purple) [18, 48], and (ii) the P+1 specificity region, located at the base of the
phosphorylation loop (Figure 3-6, green) [71]. The EPSB groove binds the region of
the phosphorylation peptide N-terminal to the phosphorylated residue, and the P+1
specificity region binds the proline directly C-terminal to the phosphorylated residue.
Catalysis occurs when the Erk2 active site cleft binds ATP, and the phosphate-binding
ribbon (Figure 3-6, yellow) and catalytic loop (Figure 3-6, red) coordinate the transfer
of a phosphate group from the ATP to the substrate phosphorylation peptide [18, 69].
Given the current understanding of Erk2 structure and function, I next defined
how post-translational device engineers might engineer the substrate recognition and
catalytic activity of the Fus3 prototypical kinase. Specifically, I wanted to outline
ways to engineer the dissociation rate, KD, with which a Fus3 prototypical kinase
binds substrates, and the catalytic rate, kt with which Fus3 phosphorylates sub-
Figure 3-6: Regions of Erk2, a mammalian MAP kinase, important in substrate specificity
and catalytic activity. Erk2 is activated by phosphorylation on the phosphorylation loop(blue) at residues Thr183 and Tyr185. Erk2 binds substrates via the CD domain (pink)
and binds substrate phosphorylation peptides via the extended peptide substrate binding
groove (purple) and P+1 specificity region (green). Catalysis occurs via the phosphate-
binding ribbon (yellow) and the catalytic loop (red). Structure elucidated by Canagarajah
et al. [18].
strates. To obtain a desired KD, one could engineer the affinity with which (i) the
Fus3 CD domain binds the substrate binding peptide, (ii) the Fus3 EPSB groove binds
universal phosphorylation peptide, or (iii) the Fus3 P+1 specificity region binds the
universal phosphorylation peptide. The universal phosphorylation peptide must be
precisely physically aligned with the kinase catalytic core for peptide phosphoryla-
tion, and thus engineering the EPSB groove and P+1 specificity region would be
difficult as there is little tolerance for error. Post-translational device engineers could
alter post-translational device KD values by engineering the affinity with which the
Fus3 CD domain binds the substrate binding peptide; however, the CD domain may
play an important role in Fus3 structure [66], and thus engineering new Fus3 CD
domains may alter Fus3 stability and catalytic activity. In engineering the Fus3-
Phospholocator, I engineered the KD of Fus3 binding to the Fus3-Phospholocator by
(i) choosing to use the innate Fus3 CD domain, EPSB groove, and P+1 specificity
region, and (ii) including within the Phospholocator the Fus3 binding peptide from
Ste7 and the Fus3 consensus phosphorylation peptide. Given the limitations in engi-
neering the CD domain, EPSB groove, and P+1 specificity region, and my experience
in engineering the interaction between Fus3 and the Fus3-Phospholocator, I chose to
develop the following set of specifications for engineering Fus3 dissociation rates. The
Fus3 prototypical kinase consists of an intact EPSB groove and P+1 specificity region,
and a CD domain that is mutated to have diminished substrate specificity. Engineers
measure the catalytic activity of the mutant Fus3, and this catalytic activity becomes
the new "wild-type" catalytic activity of the Fus3 prototypical kinase. To engineer
substrate specificity, engineers fuse orthogonal binding domains, such as SH3 [62], to
the MAP kinase and fuse corresponding docking peptides to the substrate.
To engineer the kt of a Fus3 prototypical kinase, one could engineer (i) the rate
at which the catalytic core binds ATP, or (ii) the rate at which the catalytic core
transfers the phosphate to the substrate phosphorylation peptide. The rate of ATP
binding is a property of Fus3. The rate of phosphate transfer to the substrate phos-
phorylation peptide is a property of both Fus3 and the universal phosphorylation
peptide. In engineering the Fus3-Phospholocator, I did not engineer Fus3 catalytic
activity, but instead made use of the wild-type catalytic activity of Fus3 for the Fus3
consensus phosphorylation peptide within the Fus3-Phospholocator. Given the limi-
tations on engineering Fus3 catalytic activity, and my experience in engineering the
interaction between Fus3 and the Fus3-Phospholocator, I chose to develop the follow-
ing set of specifications for engineering Fus3 catalytic activity. Engineers alter the
kt with which the Fus3 prototypical kinase phosphorylates the universal phosphory-
lation peptide by engineering the rate with which (i) the Fus3 active site cleft binds
ATP, (ii) the phosphate-binding ribbon and catalytic loop coordinate the transfer of
the phosphate group to the universal phosphorylation peptide.
Figure 3-7: The structure of three kinases that interact in series, designed using the US
model for device composition. Device 1 is shown in green, device 2 is shown in orange, and
device 3 is shown in pink. The binding domain from device 2 is fused to the kinase within
device 1, Fus3-A, and binds the binding peptide fused to the kinase within device 2, Fus3-
B. Once bound to Fus3-B, Fus3-A phosphorylates Fus3-B on the universal phosphorylation
peptide (white). Likewise, the binding domain from device 3 is fused to Fus3-B, and binds
the binding peptide fused to Fus3-C. Once bound, Fus3-B phosphorylates Fus3-C on the
universal phosphorylation peptide (white). All kinases, Fus3-A, -B, -C, are variants of the
Fus3 prototypical kinase, depicted here with the structure of the Fus3 mammalian homolog,
Erk2 [18]. The binding domains are variants of the SH3 domain [89].
Given the set of specifications I developed for engineering post-translational de-
vice kinases and substrates, the three devices designed using the US model for device
composition, shown in Figure 3-3a could be portrayed as a collection of fused protein
parts (Figure 3-7). Device 2 (Figure 3-7, orange) consists of: (i) Fus3-B, which has no
innate substrate binding specificity, and is activated via phosphorylation on a univer-
sal phosphorylation peptide (Figure 3-7, white) within the Fus3-B phosphorylation
loop, (ii) a binding domain that is fused to whatever kinase is contained within the
device connected upstream of device 2, in this case, Fus3-A, and (iii) a binding pep-
tide fused to Fus3-B that is bound by the binding domain from (ii). Likewise, device
3 (Figure 3-7, pink) consists of: (i) Fus3-C, which has no innate substrate binding
specificity, and is activated via a universal phosphorylation peptide, (ii) a binding
domain that is fused to Fus3-B, and (iii) a binding peptide fused to Fus3-C that is
bound by the binding domain from (ii).
3.3 Discussion
In order to build many different multi-device post-translational systems, engineers
need to develop a method for connecting post-translational devices with each other.
Specifically, to enable any device within a device family to be connected to any other
device, we need to develop a universal signal that serves as both input into and out-
put from all post-translational devices. Signal definition is contingent upon device
definition itself, and so I have developed a model for device composition, called the
universal signal (US) model, in which all sets of interacting domains and peptides
are contained within the same device. The universal model enables devices to com-
municate with each other via a universal signal of activity that is comprised of two
components, the concentration of an active kinase, and the catalytic activity of that
kinase toward a universal phosphorylation peptide. An upstream device output sig-
nal is directed toward the kinase within a downstream device via a set of interacting
binding domains and binding peptides within the downstream device. I have devel-
oped a set of specifications for engineering post-translational devices using the US
model. Each kinase to be used in devices designed using the US model for device
composition is engineered as a variant of the prototypical kinase, which I have chosen
to be Fus3; the prototypical kinase has been engineered to have no innate substrate
binding specificity. A device built using the US model consists of a variant of the
Fus3 prototypical kinase that is activated via phosphorylation on the universal phos-
phorylation peptide, and a cognate binding domain and peptide; the binding peptide
is fused to the Fus3 prototypical kinase within the device, while the binding domain
is fused to the Fus3 prototypical kinase within the upstream device. Kinase-substrate
specificity is dictated by the device into which the kinase activity is input, and not
by the kinase itself. By shifting the definition of a device from that of a whole kinase,
as is the standard in structural and biochemical communities, to a collection of inter-
acting protein parts, I defined a universal post-translational device signal that would
enable researchers to more readily combine post-translational devices to build many
systems in the future.
My approach is a first, exploratory step towards a simplified framework for con-
necting engineering post-translational devices to build multi-device systems. In devel-
oping the framework, I make several simplifying assumptions about kinase modular-
ity, functionality, and interactions with other proteins that may or may not adversely
impact post-translational device functionality. For example, I use protein-protein
binding as physical method to transiently connect two devices; this binding is anal-
ogous to the wires used to statically connect electrical devices. However, we do
not understand the full extent of nonspecific protein binding and phosphorylation
between our engineered devices and the endogenous yeast proteins, which may in-
fluence device behavior. As a second example of a simplifying assumption that may
affect device functionality, I assume that phosphatases non-specifically dephosphory-
late post-translational devices at a basal rate, allowing gradual device reset. However,
phosphatases may preferentially dephosphorylate certain peptides over others, thus
impacting the functionality of different devices to different extents. By removing
our assumptions about phosphatase non-specificity, we could employ phosphatase
specificity as a tool to further tune post-translational device behavior. As a third
example of a simplifying assumption that may affect device functionality, I neglect
the fact that Fus3, upon substrate binding, experiences a conformational change that
enhances kinase activity [66]. By inducing substrate binding via an independently-
folding domain instead of employing the endogenous CD domain, my guidelines for
engineering prototypical kinases may yield kinases with diminished catalytic activity.
As a fourth example of a simplifying assumption that may affect device functionality,
I assume that one universal phosphorylation peptide is sufficient to mediate a wide
range of functions, including activation, degradation, and translocation. In reality,
the universal peptide may prove incompatible with one or more types of functional
peptides such as nuclear localization signals, degradation tags, among others. As a
final example, I assume that an activating prototypical kinase can simultaneously
bind and phosphorylate a substrate engineered using the universal model for device
composition. To make this assumption valid, engineers may need to add flexible
linkers to the binding or phosphorylation peptides to enable a greater range of spa-
tial conformations and distances spanned by the peptides [68, 28, 32, 5, 41]. Other
engineering frameworks are also based upon simplifying assumptions; for example,
electrical engineers often assume that the magnetic fields generated by current flow
do not greatly impact electrical device function. Upon building a device based upon
such assumptions, engineers test if the assumptions are valid, and readjust assump-
tions accordingly. As we begin to engineer more post-translational devices using the
universal model for device composition, we will likewise test the simplifying assump-
tions I have made to determine if the assumptions must be altered to reflect the
realities of kinase engineering.
Chapter 4
Model and analysis of a
post-translational latch
4.1 Introduction
I demonstrated in Chapter 2 that engineers can build useful post-translational devices,
and outlined the benefits of connecting devices to produce more powerful multi-device
post-translational systems in Chapter 3. To connect post-translational devices in a
scalable manner, I designed a model for device composition, called the US model,
that features the universal device signal of two-component general activity, called
TGA. I also designed a set of specifications for engineering and characterizing devices
that input and output TGA. My next goal was to (i) use the US model for device
composition and the set of device specifications to design a useful multi-device post-
translational system, (ii) build a model of the system and simulate system behavior
to show that the system functions as designed, and thus serves as a proof-of-principle
that one could combine post-translational devices to implement complex functions,
and (iii) a develop a set of practical guidelines for building and implementing the
post-translational system.
Memory storage is important in both electrical and biological systems [16, 6, 90],
and thus I set out to design a simple biological memory storage system. I based
the design on an electrical device called an SR latch, which consists of two coupled
NAND gates (Figure 4-la)[16]. The output of one NAND gate serves as the input to
the other NAND gate, and system state is set by inputs S and R (Figure 4-1b).
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Figure 4-1: (A) An SR latch is composed of two interconnected NAND gates. System state
is set by inputs S and R, and read out as Q and Q. (B) The input/output characteristics
of the SR Latch.
4.2 Results
4.2.1 Design and model of a post-translational latch
To better inform the design of a post-translational latch, I considered a transcriptional
latch, or toggle switch, built by Gardner et al. from a pair of transcriptional repressors
and their cognate operators [36]. Briefly, repressor 1 was expressed by promoter 2,
and repressor 2 was expressed by promoter 1. Repressor 1 repressed expression from
promoter 1, and hence expression of repressor 2, while repressor 2 repressed expression
from promoter 2, and hence expression of repressor 1. Gardner et al. developed the
following set of equations to describe the latch behavior:
du al
dt 1+v -
dv 
_a 2
dt 1 + u•
(4.1)
(4.2)
where u and v are the concentrations of repressor 1 and 2, respectively, al and a 2
are the effective rates of synthesis of repressor 1 and repressor 2, respectively, and /
and y are the cooperativities of repression of promoter 2 and promoter 1, respectively.
In order to generate the desired toggle behavior, Gardner et al. developed a set of
constraints and assumptions about the system. First, Gardner et al. assumed that
protein-DNA binding is fast relative to transcription and translation, and thus were
able to assume a pseudo steady-state that simplified a complicated set of intracellu-
lar reactions into the two equations shown above. Second, Gardner et al. allowed
the total concentrations of repressor 1 and repressor 2 to be unbounded; thus, the
concentration of a repressor was allowed to grow as large as was necessary to tog-
gle system state. Finally, the toggle switch was made to exhibit a switch-like, or
ultrasensitive, response. A system is said to be ultrasensitive if the system exhibits
a sigmoidal stimulus-response curve, where at low concentrations of a stimulus, such
as repressor 1, changes in the stimulus result in very little change in the system re-
sponse, such as the concentration of repressor 2 (Figure 4-2). Once stimulus levels
have built up to a certain threshold, or trip point, small increases in stimulus cause a
large change in system response; further increases in stimulus cause very little change
in system response. In the transcriptional latch, ultrasensitivity is generated by the
exponents 0 and y in the equations describing latch behavior. Physically, the toggle
switch implements the ultrasensitive response via the cooperative binding of multiple
repressors to a single promoter.
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Figure 4-2: An ultrasensitive response to a stimulus
Post-translational devices implement device function via a different set of intracel-
lular reactions than do transcriptional devices, and thus my post-translational latch
necessitated a different set of constraints and assumptions than did the transcriptional
latch made by Gardner et al.. First, the analogous post-translational pseudo steady-
state approximation to that invoked by Gardner et al. is the Michaelis-Menten pseudo
steady-state approximation, in which the concentration of the kinase-substrate com-
plex is constant over time. This approximation only holds when the concentration
of substrate is much larger than the concentration of kinase. In post-translational
devices, substrates are often kinases themselves, and thus the concentration of sub-
strate is not necessarily much greater than the concentration of kinase; therefore, I
could not make the Michaelis-Menten pseudo steady-state approximation when mod-
eling my post-translational latch. A second difference between my post-translational
latch and the transcriptional latch is that post-translational device concentration is
capped, and device function implemented by changing protein state, by phosphory-
lation or another modification, instead of by changing the quantity of proteins as in
transcriptional devices. A third difference between my post-translational latch and
the transcriptional latch is that, although many proteins do form multimers, kinases
and kinase substrates rarely multimerize. Thus, ultrasensitivity in post-translational
devices must be generated by a mechanism different than that of transcriptional de-
vices.
Ferrell has elucidated several mechanisms by which a post-translational device,
such as the amplifier described in Chapters 2 and 3, can be made ultrasensitive [33].
First, kinase A could phosphorylate kinase B on two separate peptides; if kinase B is
active only when doubly phosphorylated, then the amplifier will exhibit an ultrasen-
sitive response. The phosphorylation events must be nonprocessive, meaning that,
upon binding, kinase A can only phosphorylate one substrate peptide before dissoci-
ating. Second, kinase A could both activate kinase B, and inactivate the phosphatase
that deactivates kinase B. Finally, the concentration of kinase A could approach
that of kinase B, and thus the rate of activation of kinase B would not be linearly
dependent on kinase B concentration. A priori, I was unsure which mechanism of
ultrasensitivity would be the most feasible to implement in practice. I chose to model
a post-translational latch that employs the nonprocessive phosphorylation method
of ultrasensitivity because it is straightforward to model and because I was able to
develop a set of guidelines for building such a latch (discussed below). In actually
attempting to constructing the latch, however, engineers might find that a different
method of ultrasensitivity is more practical to implement.
Given previous examples of transcriptional latches, the differences between tran-
scriptional and post-translational systems, and mechanisms of kinase ultrasensitivity,
I designed and modeled a biological latch that consists of two coupled ultrasensitive
devices; for each device, input signals of high TGA result in output signals of low
TGA, and vice versa (Figure 4-3). The first device, device 1, converts high kinase
A TGA levels into low kinase B TGA levels, and low kinase A TGA levels into high
kinase B TGA levels. The second device, device 2, converts high kinase B TGA levels
into low kinase A TGA levels, and low kinase B TGA levels into high kinase A TGA
levels. In connecting the output signal of device 1 to the input of device 2, and the
output signal of device 2 to the input of device 1, I designed a latch that implements
two states: high kinase A TGA levels and low kinase B TGA levels, or low kinase A
TGA levels and high kinase B TGA levels. One can toggle the latch between the two
states via upstream kinases that dephosphorylate kinase A and kinase B.
Kinase A and kinase B bind each other with association rate kon and dissociation
rate koff via a cognate docking domain fused to A and docking peptide fused to B.
Because association and dissociation rates in the universal device model are solely
determined by binding domains and binding peptides, the association and dissoci-
ation rates of all forms of A binding to all forms of B are the same. In order to
generate ultrasensitivity in the system, kinase A and kinase B phosphorylate each
other nonprocessively on two universal phosphorylation peptides, and phosphoryla-
tion decreases the catalytic activity of the recipient kinase. Kinase A and B are
fully active when unphosphorylated, fully inactive when doubly phosphorylated, and
partially active when singly phosphorylated. Thus, I defined different catalytic rates
for unphosphorylated kinase, singly phosphorylated kinase, and doubly phosphory-
lated kinase (equal to zero) in my latch model. In keeping with the universal device
model, the four phosphorylation peptides fused to kinase A and kinase B are all the
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Figure 4-3: The design of a post-translational latch. The latch consists of two devices,
device 1 and device 2. The input to device 1 is the TGA of kinase A, and the output of
device 1 is the TGA of kinase B, which in turn serves as the input to device 2. The output
of device 2 is the TGA of kinase A, which serves as the input to device 1. Fully active kinase
A is shown in dark purple, partially active kinase A in medium purple, and inactive kinase
A in light purple. Fully active kinase B is shown in dark orange, partially active kinase B
in medium orange, and inactive kinase B in light orange. The mechanism of each device
consists of the nonprocessive phosphorylation of the output kinase by the input kinase on
two universal peptides (white ovals); phosphate groups are depicted as stars.
universal phosphorylation peptide, and thus active kinase A phosphorylates unphos-
phorylated kinase B (B) and singly phosphorylated kinase B (Bi) at the same rate,
ktA. Likewise, active kinase B phosphorylates unphosphorylated kinase A (A) and
singly phosphorylated kinase A (Ai) at the same rate, ktB. For ease of modeling, I
designed kinase A and kinase B to have identical catalytic rates (kcatA = kcatB).
Although I could not simplify the latch reaction equations by assuming a Michaelis-
Menten pseudo steady state in the reaction between kinase A and kinase B, for ease
of modeling, I combined the association, phosphorylation, and dissociation rates of
the latch into two rate constants, kl and k3 . The rate kI represents the rate con-
stant of unphosphorylated kinase A binding and phosphorylating unphosphorylated
or singly phosphorylated kinase B, as well as the rate of unphosphorylated kinase B
binding and phosphorylating unphosphorylated or singly phosphorylated kinase A.
The rate k3 represents the rate constant of singly phosphorylated kinase A binding
and phosphorylating unphosphorylated or singly phosphorylated kinase B, as well as
the rate of singly phosphorylated kinase B binding and phosphorylating unphospho-
rylated or singly phosphorylated kinase A. In the model I set k3 to be one-half as
large as k1. In order to enable the system to be reset, I included a phosphatase in the
model that nonprocessively dephosphorylates kinase A and kinase B at a rate of k2 -
To a first approximation, the assumption that the association, phosphorylation, and
dissociation rates can be combined appears to be valid when the dissociation rate of
the kinase A-kinase B complex is slow relative to the catalytic rates of kinase A and
kinase B; in this situation, the majority of kinase A-kinase B associations will result
in product formation, and thus can be modeled as a single step. Thus, the rates kl
and k3 are limited by ko, and ko ff, and not by kt.
4.2.2 Analysis of a post-translational latch
The post-translational latch that I designed is different than the transcriptional latch
built by Gardner et al. in the way that ultrasensitivity is implemented, species con-
centrations are capped, and pseudo steady-state assumptions are invoked, and thus I
was unsure if my post-translational latch model, as designed, could indeed implement
memory storage. Therefore, I simulated post-translational latch behavior using the
model, and analyzed it for features common to memory storage devices. Given previ-
ous research into biological memory-storage devices [36, 12], I concluded that in order
to function properly, the biological latch must exhibit three steady-states, where lev-
els of the six protein species (unphosphorylated, singly phosphorylated, and doubly
phosphorylated kinase A and B) remain constant over time. Two of these steady-
states must be stable, meaning that if small perturbations shift the system away from
the stable steady-state, the system will eventually return to the same stable steady
state. One stable steady state represents a situation where kinase A TGA is high
and kinase B TGA is low, and the other stable steady-state represents a situation
where the kinase B TGA is high and the kinase A TGA is low. The third steady-state
must be unstable, meaning that if small perturbations shift the system away from
the steady-state, the system will move to one of the two stable steady states and not
back to the unstable steady-state. The unstable steady state represents a situation
where both kinase A and kinase B exhibit identical TGAs, and thus are balanced at
a metaphorical kinase stalemate.
I encoded the model using MATLAB technical computing software, and numer-
ically solved a system of ODEs describing the post-translational latch for k1 values
between 10- 4 and 10-2 nM-1s - 1, k2 values between 10- 3 and 102 s- 1, and k3 values
between 5x10- 5 and 5x10-3 nM-'s - 1 (Methods). I chose k1 and k3 values correlating
with observed kon rates, and k2 values correlating with observed koff rates [59, 73, 4].
For each set of rate constants, I allowed the initial concentration of each specie to
range from 1 nM to 10 JM to ensure that I found all possible latch steady-states. I
set total levels of kinase A and kinase B to be 10 pM. I found that, for the range
of parameter values tested, the latch exhibited either one or three fixed points (Fig-
ure 4-4).
To further investigate latch behavior, I selected a set of parameters that yielded
a latch with three steady states, (kl, , k2, k3) = (10-3, 10- 2, 10-4), and called a latch
with these parameters the "prototypical" latch. The steady states of the prototypical
latch exist in six-dimensional space, which is difficult to visualize, and thus I next
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Figure 4-4: The number of steady states exhibited by my post-translational latch for a
range of k1 and k2 parameter space. Systems exhibiting three steady states are shown in
yellow; systems exhibiting one steady state are shown in blue.
reduced the dimensionality of the model. The total concentrations of kinase A and
kinase B were fixed at 10 pM, and so it was sufficient to follow concentrations of un-
phosphorylated kinase A, singly phosphorylated kinase A, unphosphorylated kinase
B, and singly phosphorylated kinase B, as I could calculate doubly-phosphorylated
kinase A and doubly-phosphorylated kinase B by subtracting the unphosphorylated
and singly phosphorylated species from the total concentrations. I thus considered
a four-dimensional space of kinase concentrations. I further noted that the three
steady-states lie on a common four-dimensional plane, and transformed the plane to
exist in two dimensions, those of unphosphorylated kinase A and singly phospho-
rylated kinase A (Methods). Within the transformed plane, the transformed levels
of unphosphorylated kinase B and singly phosphorylated kinase B remain constant
(Figure 4-5).
I next determined if each steady state was stable or unstable in the two-dimensional
plane by numerically solving the system of ODEs describing the system with a range
__
Point Coordinates A A, A, B B, B,
a 0 20 9980 3310 3330 3350
Regular 3310 3330 3350 0 20 9980
20 420 9560 20 420 9560
a 4670 290 - 340 -300 -
Transformed -300 4670 - 340 -300 -
y 250 290 - 340 -300
Figure 4-5: The steady state levels of all forms of kinase A and kinase B for all three
steady-states, in both regular and transformed coordinates
of initial concentrations along the two-dimensional plane, and observing the steady-
state concentrations reached by the system. In other words, I explored the regions
around each steady-state, called the domains of attraction, that, once entered into by
the system, result in the system being drawn into that steady-state (Figure 4-6). I
found that points a and 3 were stable steady-states, as each had a sizable domain of
attraction. Point ~ was an unstable steady-state, as there was no domain of attraction
of y.
4.2.3 Practical guidelines of a post-translational latch
Given the constraints inherent in post-translational systems, in the previous section
I designed a model of a post-translational latch (Figure 4-3) and demonstrated that
the latch should behave as designed for a range of parameter values. I next developed
a set of guidelines by which engineers could build the latch. Using the US model
for device composition that I outlined in Chapter 3, kinase A and kinase B are Fus3
prototypical kinases, called Fus3-A and Fus3-B, with identical catalytic activities.
The phosphorylation loops of Fus3-A and Fus3-B are mutated such that Fus3-A and
Fus3-B are constitutively active. While, to my knowledge, researchers have not yet
built constitutively active Fus3 mutants, Bell et al. have built mutants of p38, a mam-
malian MAP kinase, that were constitutively active [11]. These mutants contained
single point mutations within the L16 domain of p38.
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Figure 4-6: The domains of attraction of steady-states a (orange) and 3 (green) in the
transformed coordinates. Steady-state y is an unstable steady-state, and thus has no domain
of attraction.
Fus3-A and Fus3-B each contain two universal phosphorylation peptides within or
near the kinase phosphorylation loop that are phosphorylated by Fus3-B and Fus3-A,
respectively. The two added phosphate groups mediate a decrease in catalytic activity
by binding a dual-pocket binding domain either in cis or in trans that recognizes
the two phosphorylated universal phosphorylation peptides in concert; binding of
the dual-pocket binding domain to the peptides disrupts kinase catalytic activity,
substrate affinity, or both. Singly phosphorylated Fus3-A and Fus3-B is partially
inhibited, as the dual-pocket binding domain still binds the kinase, albeit at a lower
affinity.
Fus3-A binds to Fus3-B via a binding domain attached to Fus3-A, such as SH3,
and a cognate binding binding peptide attached to Fus3-B. When bound to Fus3-B,
Fus3-A is spatially positioned such that it can phosphorylate Fus3-B, and Fus3-B
is spatially positioned such that it can phosphorylate Fus3-A. The main challenge
in engineering the binding interaction between Fus3-A and Fus3-B is to ensure that
the kinases phosphorylate each other only once per binding event, because nonpro-
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cessive binding is compulsory for latch ultrasensitivity. I specify two mechanisms in
which engineers could design Fus3-A and Fus3-B to dissociate between phosphoryla-
tion events. First, engineers could specify the dissociation rate of the Fus3-A-Fus3-B
complex to be greater than the catalytic rate of Fus3-A or Fus3-B; in such a case,
the proteins are likely to dissociate before the kinase can phosphorylate the substrate
a second time. However, this constraint contradicts an assumption that I made in
building the latch model; I assumed that the dissociation rate must be slow compared
to the catalytic rate in order to describe binding, phosphorylation, and dissociation
with one first-order rate constant. Therefore, engineers wishing to engineer the dis-
sociation rate to be greater than the catalytic rate in order to generate nonprocessive
phosphorylation would need to build a different model for latch function. This model
would include with four additional species, AB, AiB, ABi, and AiBi, and split the
rate constants kI and k3 into ko,, kf i, ktA, and kmtB, and ko,, koff, kcatAi and ktB•,
respectively. A second way that engineers could engineer nonprocessive phosphory-
lation would be to design the binding domains and peptides such that Fus3-B blocks
ATP from entering the Fus3-A active site cleft when Fus3-A is bound to Fus3-B;
thus, Fus3-A and Fus3-B must dissociate in order bind ATP. I do not know how easy
or difficult it would be to engineer Fus3-A to block the Fus3-B active site cleft, and
vice-versa. MAP kinase-activating proteins (MEKs) have been shown to phosphory-
late MAP kinases nonprocessively [17, 34], and thus it is clearly possible to engineer
nonprocessive kinases. If engineering a nonprocessive kinase proves exceedingly dif-
ficult to implement in practice, however, engineers could employ a different method
of ultrasensitivity, such as Fus3-A both phosphorylating and inhibiting Fus3-B, and
phosphorylating and inhibiting a phosphatase that acts on Fus3-B.
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4.3 Materials and Methods
4.3.1 System of ODEs
I defined a system of ordinary differential equations to describe the behavior of the
latch:
dA
= -kIAB - k3ABi + k2Ai (4.3)dt
dAid- = kAB + k3ABi - k2Ai - klAiB - k3AiB i + k2Aii (4.4)dt
dAiii- = klAiB + k3AiBi - k2Aii (4.5)dt
dB
= -kIBA - k3BAi + k2Bi (4.6)dt
dB-
= klBA + k3BAi - k2Bi - klBiA - k3BjAj + k2Bii (4.7)dt
dBiid = kiBiA + k3B1AI - k2Bii (4.8)dt
where A is the intracellular concentration of unphosphorylated kinase A, Ai is the
concentration of singly-phosphorylated kinase A, Aii is the concentration of doubly-
phosphorylated kinase A, B is the intracellular concentration of unphosphorylated
kinase B, Bi is the concentration of singly-phosphorylated kinase B, and Bii is the
concentration of doubly-phosphorylated kinase B. The rate kI describes the rate at
which A binds and phosphorylates B or Bi, and the rate at which B binds and
phosphorylates A or Ai. The rate k3 describes the rate at which Ai binds and phos-
phorylates B or Bi, and the rate at which Bi binds and phosphorylates A or Ai.
The rate k2 describes the rate at which Ai, Aii, Bi, and Bii lose a phosphate group
via a phosphatase. I coded these ODEs into file ff_ODEsv2.m (MIT DSpace DOI
http://hdl.handle.net/1721.1/41535).
4.3.2 Determining the number of steady state points
To determine the number of steady states across a range of parameters, I developed
the MATLAB file latch ssutton.m (MIT DSpace DOI http://hdl.handle.net/1721.1/41531).
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Briefly, I varied kl values between 10- 4 and 10- 2 nM-ls - 1 , k 2 values between 10- 3
and 102 s - 1 , and k3 values between 5x10 -5 and 5x10 -3 nM-'s - 1 and for each set of
parameter values used the fsolve function to determine the steady-state concentration
values of the ODEs describe above, and stored in file gook3_v3.m (MIT DSpace DOI
http://hdl.handle.net/1721.1/41532). Gook3_v3.m is the same as ffODEs_v2.m ex-
cept that, to force conservation of mass, I included the conditions that A + Ai + Aii =
AT and B + B, + Bii = BT. For each set of rate constants, I allowed the initial
concentration of each specie to range from 1 nM to 10 pM in order to ensure that I
found all possible latch steady-states. I set total levels of kinase A and kinase B to be
10 pM. For each set of parameters, I determined the number of distinct steady-states
found by fsolve. I defined a distinct steady state to be one in which steady-state con-
centrations of all protein species differed from the concentrations of the corresponding
protein species in other steady-states by atleast 40%, or 1 nM, whichever was larger.
4.3.3 Determining the regions of concentration space that
converge on the stable steady-states
To determine the domains of attraction of the three steady-states for a desired set
of parameters, I further developed the MATLAB file latchssutton.m (MIT DSpace
DOI http://hdl.handle.net/1721.1/41531). I first transformed the four-dimensional
system of (A, Ai, B, Bi) into a two-dimensional plane that contains the three steady-
states. To perform the transformation, I found two vectors, I and - that uniquely
define the plane containing the three steady states by subtracting the coordinates of
steady-state 2 from the coordinates of steady-state 1, and subtracting the coordinates
of steady-state 2 from the coordinates of steady-state 3, respectively. I found a vector,
Bo-th, that is perpendicular to I and lies in the plane defined by the three steady-
states using the following formula:
Borth (4.9)
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I next chose two vectors, - and ~, that are perpendicular to the plane defined by
A and Borth such that:
< , V >=< A, V >=< Bor-th, - >=< Bort7 >= 0 (4.10)
This system is underdetermined, so I set the following coordinates, and solved for the
rest algebraically:
(2) = 1 (4.11)
V(3) = 0 (4.12)
_V(2) = 1 (4.13)
V(3) = 0 (4.14)
I normalized A, Bor~h , , and V and found a vector, Do that is perpendicular to
8 and lies in the plane defined by - and V using the following formula:
Doth = 1- (4.15)
I combined the vectors to form the transform T = [V,, Bor-h, , Dor-th]. Multiplying a
vector or system by T transforms the system into the four-dimensional basis defined
by V, Borth, C, and Dorth. I thus found the coordinates of the three steady-states
in the new four-dimensional space by taking the inverse transform of the regular
steady-state coordinates.
4.4 Discussion
Using the US model for device composition, I designed a functional post-translational
latch capable of maintaining two stable steady-states. The post-translational latch
is different than the previously-engineered transcriptional latch because (i) the post-
translational latch does not allow for pseudo steady-state approximations, as opposed
to the translational latch which does allow for steady-state approximations, (ii) post-
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translational device concentrations are capped, and not unbounded as in the tran-
scriptional latch, and (iii) ultrasensitivity in the post-translational latch is generated
by nonprocessive phosphorylation, and not multimerization as in the transcriptional
latch. Because of the differences in the post-translational latch and the transcrip-
tional latch, the successful implementation of a transcriptional latch did not imply
that a post-translational latch could also be successfully implemented. Thus, I de-
veloped a set of design constraints and assumptions for a post-translational latch,
and used the constraints to model a post-translational latch. Model simulations and
analysis showed that the post-translational latch did indeed function as desired, with
two stable steady-states and one unstable steady state. Given the success of my post-
translational latch simulations, I outlined a set of guidelines by which engineers could
set about implementing my post-translational latch in yeast cells.
A post-translational latch would be a useful first post-translational system to
build, for several reasons. First, the latch implements memory storage, which is
a fundamental function that would enable many other types of post-translational
systems to be built in the future. Second, the latch is a non-trivial system to design
and build, but has few enough parts that it is conceivable that the latch could be
built in the near future. Third, in building the latch, researchers will develop methods
to generate ultrasensitivity in post-translational devices. Given the importance of
ultrasensitivity in natural biological systems, ultrasensitivity will likely play a key
role in post-translational devices of the future.
I outlined methods for characterizing post-translational latches, and identified
ways to tune device behavior. I determined an acceptable range of parameter val-
ues over which the latch would exhibit three steady-states; engineers could control
steady-state protein levels by altering the rate constants kI and k2. Additionally, I
investigated how much of a perturbation is needed to induce a flip from one steady
state of my prototypical latch to another; this information would enable users to
toggle latch "memory" between the two stable steady-states. To further elucidate
the domain of attraction of each steady-state, it would be useful to explore initial
concentrations beyond the scope of the two-dimensional plane containing the three
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steady-states. Additionally, researchers could use my model to determine the switch-
ing time required to toggle between latch states. The transcriptional latch required
five hours to toggle between states [36], and I expect that, given the speed of the
reactions involved in the post-translational latch compared to those involved in the
transcriptional latch, the post-translational latch should switch states faster than did
the transcriptional latch.
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Chapter 5
Conclusions and future directions
5.0.1 The accomplishments of my work on post-translational
devices
Given the potential utility of post-translational devices in engineering organisms to
perform useful functions, my goal was to work on improving the process of engi-
neering post-translational devices so that other engineers can more easily build post-
translational devices in the future. I developed a framework for engineering post-
translational devices that divides a post-translational device into coupled sets of re-
actions, called "input" and "output" reactions, that can potentially be individually
engineered and recombined to engineer new devices. I outlined several methods for
engineering and coupling the input and output reactions, and then designed and built
a protein scaffold, called the Phospholocator, that enables researchers to couple var-
ious input reactions with a common output reaction, nuclear translocation. Upon
phosphorylation of the Phospholocator by an upstream kinase, the Phospholocator
remains in the cytoplasm; unphosphorylated Phospholocator is imported into the
nucleus. I built and tested two Phospholocator devices with different input reac-
tions, one that is phosphorylated by the yeast cyclin-dependent kinase Cdc28, and
one that is phosphorylated by the yeast mitogen-activated protein kinase Fus3, and
demonstrated that the two Phospholocator devices function as designed. Finally, I
demonstrated that the Cdc28-Phospholocator can potentially be used as a tool for
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biological discovery.
Having successfully built two post-translational devices, I more closely examined
post-translational device signals. To implement complex functions, engineers will
connect post-translational devices together to build multi-device systems. I explored
the challenges inherent in connecting post-translational devices with each other, and
developed a model for device composition, called the "universal signal" model that
features a universal signal carrier that is both input into and output from post-
translational devices. The universal signal enables engineers to easily combine devices
in any desired order, and thus build many new post-translational systems. I detailed
the advantages and disadvantages of the universal signal model, and developed a set
of specifications and guidelines for designing prototypical protein parts for engineering
post-translational devices that communicate via the universal signal carrier. Finally,
I described how engineers could build a string of two post-translational amplifiers
using the universal signal model.
Having demonstrated that engineers can build useful post-translational devices,
and defined a universal device signal that should enable post-translational devices to
be interconnected, I used the universal signal model for device composition and the
corresponding set of device specifications I developed to design a proof-of-principle
multi-device post-translational system, a post-translational latch. I built a model
of the latch, simulated latch behavior, and demonstrated that the model functioned
as designed. Finally, I developed a set of practical guidelines for building and im-
plementing the post-translational latch. Taken together, my initial experiences in
engineering post-translational devices, defining universal device signals that enable
device interconnectivity, and designing, modeling, and analyzing a functional multi-
device system, along with the work of many other groups, are sufficiently encouraging
to motivate continued work on post-translational device technologies in the future.
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5.0.2 Future directions in post-translational device engineer-
ing
There are several ways in which the Phospholocator scaffold could be expanded upon,
to further the utility and diversity of post-translational devices. In building the
Cdc28-Phospholocator and Fus3-Phospholocator, I have engineered modular input re-
actions that interface with a common output reaction. In the future we could similarly
engineer modular output reactions, such as degradation, nuclear export, and activa-
tion. For example, we could engineer the Phospholocator scaffold to couple Cdc28 or
Fus3 input reactions with degradation-based output reactions instead of localization-
based output reactions; we would call such a device scaffold the Phosphodegrador.
The input reactions to the Phosphodegrador would result in the phosphorylation of
a phosphorylation peptide embedded within a degradation peptide. The phosphory-
lation peptide could regulate the output reaction of Phosphodegrador-based devices
by, when phosphorylated, enhancing binding of the degradation peptide to the ubiq-
uitination machinery via the steric regulation mechanism [23]. The main challenge in
engineering a Phosphodegrador scaffold would be to embed a phosphorylation peptide
within a degradation peptide, thereby producing a composite part that can be both
phosphorylated by an input kinase and recognized by the ubiquitination machinery;
such a part could be produced either rationally or via screening. As we begin to build
more input and output reactions, we should expect to learn how to better couple
phosphorylation peptides with output reaction peptides.
The Phospholocator should be useful for biological purposes other than measuring
kinase activity in vivo. For example, by fusing a library of candidate docking and
phosphorylation peptides to the Phospholocator, and testing which peptides produce
in a shift in Phospholocator location, it may be possible to identify new docking and
phosphorylation peptides for target kinases. We could improve the ease of Phospho-
locator peptide screens by fusing a DNA binding and transcription activation domain
to the Phospholocator scaffold; by regulating Phospholocator location, we could thus
regulate gene expression. Because gene expression rates can be sensitive even to low
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nuclear concentrations of a transcriptional activator, to build a useful Phospholocator
screening scaffold we might need to tune the nuclear export rates of the Phospholoca-
tor such that Phospholocator levels swing from entirely cytoplasmic when phospho-
rylated, to only slightly nuclear when unphosphorylated. Beyond screening and selec-
tion, phospho-regulation of gene expression would also allow Phospholocator-based
devices to connect with transcriptional devices, enabling additional applications.
Other useful projects to enhance the diversity and utility of post-translational de-
vices could include: (i) engineering a greater variety of docking and phosphorylation
peptides, (ii) engineering devices that utilize other types of post-translational modi-
fications, (iii) developing next-generation kinases that are engineered to have desired
binding and phosphorylation peptide specificity, (iv) developing better quantitative
models of post-translational devices, and (v) interfacing post-translational devices
with other types of biological devices. First, using screening methods, we should be
able to develop more docking and phosphorylation peptides, which would in turn
enable engineers to build post-translational devices with a greater range and finer
resolution of binding affinities and phosphorylation rates. Second, we can imagine
engineering devices in which device function is regulated by other types of post-
translational modifications, such as glycosylation or methylation, that target devices
to different intracellular compartments or regulate interaction with new binding part-
ners. Third, we could potentially develop not just substrate scaffolds, such as the
Phospholocator, but also kinase scaffolds that consist of generic kinase structures
devoid of specificity or activity, onto which we could fuse well-characterized bind-
ing domains, such as SH3 domains, and catalytic cores specific to desired substrates
with desired catalytic activities. Kinase scaffolds and substrate scaffolds would allow
engineers greater flexibility in designing input and output reactions than substrate
scaffolds would alone. Fourth, we could measure the kinetic parameters associated
with post translational device function, such as the rates of kinase activation, the
rates of device phosphorylation, the affinity between the nuclear import machinery
and devices, and the rate of nuclear import of the import machinery, and use this
data to develop models of device function that help engineers to better understand
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and predict device behavior. Finally, we could possibly interface post-translational
devices with other types of biological devices, such as transcriptional devices, post-
transcriptional devices, and metabolic devices, to allow an even greater diversity of
device and system function. Taken together, these next steps would allow for the
engineering of many, still more useful, engineered post-translational devices.
5.0.3 Future directions in connecting post-translational de-
vices to form systems
In Chapter 2, I developed the universal signal (US) model for device composition
that features a universal signal carrier that is both input into and output from post-
translational devices. I outlined a set of design specifications and guidelines for en-
gineering kinases and substrates to be used in devices built within the US model; a
next step would be to engineer such kinases and substrates to both demonstrate the
feasibility of my guidelines, and to better educate engineers about the modularity of
kinase structures. I proposed to use Fus3 as a "prototypical" kinase that serves as
a template from which to engineer many derivative kinases with different catalytic
activities. To use Fus3 as a prototypical kinase, we must alter Fus3 structure in three
main ways. First, we must mutate the common docking (CD) domain of Fus3 to
eliminate existing Fus3 binding specificity, and test the resulting activity of Fus3 to
ensure that the CD mutations don't render Fus3 catalytically inactive. Second, we
must engineer variants of the catalytic site of Fus3 to produce Fus3 derivatives with a
variety of catalytic activities (kt values). We could potentially alter the catalytic ac-
tivity of Fus3 by engineering the affinity with which (i) the Fus3 active site cleft binds
ATP, (ii) the phosphate-binding ribbon accepts a phosphate group from the ATP, or
(iii) phosphate-binding ribbon transfers the phosphate group to the universal phos-
phorylation peptide via the catalytic loop. Third, we must fuse binding domains,
such as SH3, and binding peptides to Fus3, either at the termini or within loops, and
test the resulting stability of Fus3. Additionally, to build a variety of devices with
different binding affinities, it would be beneficial to construct a library of binding do-
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mains and binding peptides, and characterize the affinity between cognate domains
and peptides. We must also determine the cross-reactivity of non-cognate domains
and peptides, so as to avoid undesirable crosstalk in engineered post-translational
systems.
I proposed to develop a universal phosphorylation peptide that is incorporated
in all post-translational devices such that a given Fus3 derivative kinase will phos-
phorylate all devices at the same catalytic rate. We must first design the sequence
of the universal phosphorylation peptide; the consensus Fus3 phosphorylation pep-
tides elucidated by Drs. Yaffe and Lim and used in the Fus3-Phospholocator serves
as a potential candidate. We must then develop a measurement platform that en-
ables researchers to characterize the catalytic activity of Fus3 derivative kinases with
respect to the universal phosphorylation peptide. Additionally, for each functional
post-translational part that we wish to interlace with the universal phosphorylation
peptide, such as the Swi5 NLS within the Phospholocator, we must characterize the
effect of the interwoven universal phosphorylation peptide on part functionality, both
in the unphosphorylated and phosphorylated forms.
In order to test out the functionality and utility of the Fus3 prototypical kinase
and the universal phosphorylation peptide, researchers could begin to build devices
and systems using these parts. Researchers could implement the latch described in
Chapter 3; to do so, researchers could implement at least one of the mechanisms for
ultrasensitivity that I outlined in Chapter 4. Once the mechanism for ultrasensitivity
has been successfully implemented, researchers could use ultrasensitivity to build
other complex post-translational systems such as counters and signaling networks.
In summary, my work in developing frameworks for engineering and interconnect-
ing post-translational devices suggests that at least one family of post-translational
devices can be built and, given continued work, may potentially be interconnected to
implement new intracellular systems. Post-translational devices, in combination with
transcriptional, post-transcriptional, and metabolic devices, could potentially allow
researchers to reprogram microogranisms to perform useful tasks, and herald an era
of adaptable, self-replicating, self-preserving machines that can implement a new set
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of functions that benefit mankind.
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